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INTRODUCTION 
Pleural effusion is defined as the abnormal collection of pleural fluid in 
between the two layers of the pleural as result of imbalance in the homeostatic 
factors that govern the rate of pleural fluid formation and absorption.The global 
incidence of pleural effusion is estimated to be around 3 million perannum. 
Thus it is important to exactly diagnose the cause of pleural fluid formation and 
there by reducing the mortality and morbidity associated with the same. Pleural 
fluid originates from the capillaries of the parietal pleura at a rate of 
0.01ml/kg/hr and is cleared at a rate of 0.4ml/kg/hour. 
In normal individuals the approximate amount of pleural fluid present is                       
8.4  4.3ml and the normal pleural fluid composition shows that the mean total 
cell count is 1716 cells/mm3 and mean red cell count being 700 cells/mm3.In 
humans approximately 75% cells in pleural fluid are macrophages,25% being 
lymphocytes and mesothelial cells and finally eoisnophils and neutrophils 
totally comprising of 2% of the cellular population of pleural fluid analysis. 
Pleural fluid accumalation occurs when the pleural fluid formation exceeds the 
rate of pleural fluid absorption. Various theories have been proposed for the 
same,of which three basic mechanisms have been identified; 
1. Increased hydrostatic pressure 
2. Increased Capillary permeability 
3. Decreased oncotic pressure. 
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These three basic underlying pathogenic process have been implicated in 
the formation of pleural effusion due to any cause(either systemic or localised 
pathology).Thus a knowledge about the underlying pathogenic process gives an 
idea about the etiology of the pleural effusion. Generally pleural effusions were 
classified as transudates (secondary to systemic causes like CCF,renal 
failure,decompensated liver diseases) or exudates(infectious causes). Exudative 
effusions further classified into parapneumonic, tubercular and malignant 
effusions. This sub classification of exudative effusions is important as the line 
of management differs for  each 
Traditionally the classification into exudative and transudative effusions 
were based on pleural fluid and serum proteins which had a lot of 
disadvantages and led to misclassification of pleural effusions. Thus the need 
for a proper diagnostic criteria was essential for correctly classifying the 
pleural effusions. Light  et  al (4) in 1972 proposed the Lights criteria for the 
same which states: 
1. Pleural fluid LDH/SerumLDH >0.6 
2. Pleural fluid LDH >200IU/L 
3. Pleural fluid protein/Serum protein >0.5 
It was further stated that in the presence of any one of the following 
criteria ,pleural fluid was diagnosed as exudative, while failure to fulfillment of 
any of the above criteria ,pleural fluid was said to be transudative. Lights 
criteria stood the test of time as the gold standard for diagnosis of pleural 
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effusions for nearly four decades .However several prospective studies were 
unable to reproduce the results of Lights criteria. It was found that in most of 
these studies Lights criteria had >95% sensitivity for exudates but the 
specificity was <78%.This led to a large number of exudates being 
misclassified as transudates which altered the treatment modalities for the 
same. 
Various other characterstics of the pleural fluid such as the appearance, 
presence of loculations ,estimation and evaluation of pleural fluid glucose, 
pleural fluid pH, ADA were used to further aid in the diagnosis of pleural 
effusions. However, all the above mentioned criteria were not specific, they  
had a lot of pit falls which led to further misclassification of pleural effusion 
happened. This lead to the search of newer biomarkers for the same and 
initially the pleural fluid cholestrol measurement was seen as a likely 
biomarker along with the traditional Lights Criteria. Thus the Modified Lights 
Criteria was introduced which inturn contributed to the estimation of pleural 
fluid cholestrol as a biomarker along with routine Lights Criteria for 
classification of exudates and transudates which also had certain drawbacks.  
This lead to the search of newer biomarkers  to aid in the classification of 
pleural effusions and various biomarkers were studied which included pleural 
fluid NT ProBNP, soluble mesothelial related proteins, pleural fluid CRP These 
biomarkers when used along with the traditional Lights Criteria were found to 
serve as a diagnostic tool for the classification of borderline cases. 
4 
 
Amongst these biomarkers, pleural fluid CRP is being widely studied as 
an adjunct along with Lights Criteria for the classification of transudates and 
exudates. C Reactive Protein is an acute phase reactant which is released by the 
hepatocytes in the liver during an ongoing inflammatory process.It is of two 
types, hs CRP and ls CRP of which ls CRP is more sensitive marker for 
inflammatory reaction. Various prospective studies also showed the importance 
of pleural fluid CRP as a sensitive biomarker in differentiating exudative 
effusions and further it also helped in differentiating parapneumonic effusions 
from malignant effusions. 
Further on CRP was released into the blood stream during the initial 
course of any inflammatory reaction in the body(infectious, malignant),this was 
further supported by the fact that in pleural space CRP is not normally seen and 
its presence in pleural fluid was a result of its diffusion from plasma. This 
formed the very basis of estimation of pleural fluid CRP in infectious and 
malignant effusions, which has good clinical reliability as shown in various 
publications. This reliable nature of pleural fluid CRP led to it being studied in 
a detailed manner through various clinical trials. 
Further on estimation of pleural fluid CRP was also a cost effective 
procedure and required minimal man power for estimation of the same. Taking 
into consideration all the advantages of using pleural fluid CRP as a biomarker 
it was stated that pleural fluid CRP could be used a potential biomarker along 
with Lights Criteria for classification of pleural effusions and further on it had 
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a good sensitivity and specificity for the identification of parapneumonic 
effusions and thus it helped differentiate parapneumonic from other effusions. 
An intense inflammatory process like  a parapneumonic effusion  had a higher 
pleural fluid CRP than tubercular or a malignant effusion. Thus pleural fluid 
CRP helped in discrminating transudates from exudates as well as seperating  
infectious from  non infectious causes.               
Thus taking into consideration the need for newer biomarker for pleural 
effusion and the benefits of pleural fluid CRP, it was considered as reliable 
adjunct along with Lights Criteria .In this study we evaluate the role of CRP in 
differentiating transudative from exudative effusions and further on to 
differentiate between the different types of exudative effusions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aims & Objectives 
 
6 
 
 
AIM OF THE STUDY  
 
Primary Aim 
1. To   study  the diagnostic use of pleural fluid CRP as a biomarker in 
differentiating  exudative from transudative effusions 
 
Secondary Aim 
2. To  correlate  the value of pleural fluid CRP  with the clinic radiological 
picture and to  differentiate  exudative effuions of varying etiology 
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OBJECTIVE 
 
Primary Objective 
To   categorize  pleural effusions  as  transudates  or exudates  based  on 
pleural  fluid  CRP  values 
 
Secondary  Objective 
To  assess the  diagnostic  value of  pleural fluid CRP  in exudative 
effusions of different  etiology 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Materials and 
Methods  
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MATERIALS AND  METHODS 
The  study  aims  at  justyfing  the  use  of  pleural fluid CRP as  a 
diagnostic  marker  in  the  differentiation of  pleural effusion of varying  
etiology 
Study  Type 
Prospective Observational Study 
 
Study Duration 
12 months 
 
Study  Locale 
PSG  Institute of  Medical Sciences and Research 
 
Study  Method: 
Convinient Sampling 
 
Sample  Size: 
60  subjects 
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Inclusion  Criteria 
1. Age  18 years and above 
2. Willingness to participate 
3. All cases  of pleural effusion:  Radiological evidence  significant  for  
diagnostic thoracocentesis 
Exclusion  Criteria 
1. Pregnant  and  Lactating  Women 
2. Mentally challenged who  are  unable to give consent 
3. All conditions which are contraindication for  performing  a  diagnostic 
thoracocentesis 
 
DIAGNOSTIC CRITERIA FOR SPECIFIC PLEURAL  EFFUSION 
1. Tubercular Effusion 
a. Exudative  pleural  effusion  with  predominantly  lymphocytic  
prominence and  a few  mesothelial cells 
b. Fever, cough, pleuritic chest pain  ,toxemia which are compatible with 
the diagnosis of a tubercular pleural effusion 
c. Response  to antitubercular  therapy 
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2. Malignant Pleural  Effuison 
a. Demonstration  of  mesothelial cells  on cytological  examination  of  
pleural fluid 
b. Demonstration  of  malignant  tissue  in  a pleural  biopsy specimen 
c. Histologically  proven  primary  malignancy  with  the  exclusion  of  
any  other  cause  kown  to  be  associated  with  the  pleural  effusion 
3. Parapneumonic Effusion 
a. .Exudative  effusion  with  neutrophilic  or  lymphocytic  
predominance 
b. Pleural  fluid  LDH >twice the serum  LDH values  and pleural  fluid  
ADA  <  30 mg/dL 
c. Pleural fluid  cytology  negative  for  malignant  cells 
d. Positive  response  to  antibiotic  therapy 
4. Transudative Effusion 
a. Clinical  evidence  of  other  system failure  such  as  congestive heart 
failure, chronic  liver  disease  or  chronic  renal  failure 
b. Lymphocytic  predominance  in pleural  fluid cytology 
c. A  positive  response to  diuretic  therapy as  evidenced by  clearance  of 
pleural effusion 
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STUDY  METHODOLOGY 
 
STEP1: 
Fulfilment  of  the  inclusion  criteria 
 
 
STEP 2 
Clinical  and  radiological  profile  for  assessing  the pleural  effusion 
 
 
STEP 3 
Diagnostic  Thoracocentesis 
 
 
STEP 4 
Routine  pleural  fluid  parameters assessed and classified  as  exudates / 
transudates  based on  Lights  criteria 
 
 
STEP  5 
Pleural  fluid  CRP  assessd  using  nephelometric  method (BECK MANN 
COULTRE  IMMAGE  800  and  calculated  in   mg/dL 
 
 
STEP 6 
Classifying  the  pleural  effusion 
 
Data  Analysis 
Spss  Software  Version 20 
  
 
 
 
 
 
Review of Literature 
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REVIEW  OF  LITERATURE 
Pleural effusion is a common occurrence seen during routine clinical 
practice, which is a result of varied systemic and local inflammatory pathology.  
 
Steven A Sahn (1) in a study concluded that the global incidence of 
pleural effusion to be 3.5 million per annum. A detailed clinical history, a 
careful physical examination , appropriate blood investigations, a systematic 
interpretation of the chest radiographs  goes a long way in the diagnosis and 
further management of a pleural effusion prior to diagnostic thoracocentesis 
itself. For eg: a massive effusion with no shift of  mediastinum to the opposite 
side with features of grade 4 MMRC dyspnea is likely that it may be a 
malignant effusion. 
Physical findings however depends on the volume of pleural fluid and 
degree of lung compensation due to the same .In a pleural fluid measuring 
approximately 500ml the above mentioned typical findings can be elicited, but 
this is not always the case in patients with minimal pleural effusion wherein a 
diagnostic thoracocentesis can be helpful in further confirming  the diagnosis A 
diagnostic thoracocentesis  and pleural fluid analysis further adds to the likely 
diagnosis or will help the clinician to rethink  and search for an alternative 
diagnosis for the same. Also helping further diagnosis is the colour and 
characteristics of the pleural fluid during thoracocentesis..  
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Porcel et al(2) in a study stated that malignancy as a cause for a frank 
blood stained pleural fluid, further on added the same to be seen in case of 
effusion due to pulmonary embolism also. However he stated that in reality 
only 11% of the malignant pleural effusions were bloody .Contrary to the belief 
that transudates were watery in appearance, Porcel et al(2) proved through a 
large multicentric study involving 766 patients where in 67% of the 
transudative effusions were straw coloured, 11% were bloody effsuions and 
around 9% were turbid in nature. Thus the pleural fluid appearance and 
characteristics were not conclusive of the exact etiology of pleural effusion. 
 Pleural fluid originates in the capillaries of the parietal pleura, normally 
at rate of 0.01ml/kg/hr and is  cleared at  a  rate  of 0.4ml/kg/hr. This steady 
clearance of pleural fluid results  in  achieving normal homoeostasis between 
pleural fluid production and pleural fluid absorption thereby ensuring that there 
is adequate layer of pleural fluid between the parietal and the visceral pleura, so 
as to avoid the friction between the two surfaces during normal respiration. The 
normal amount of pleural fluid is 8.4+/-4.3ml  between  the two  pleural 
surfaces. 
Pleural fluid tends to accumulate when the rate of pleural fluid 
formation exceeds the rate of pleural fluid absorption and varied medical 
conditions are known for causing the same via different but similar 
mechanisms.  These include  (1)-increased pleural membrane permeability, (2)-
increased pulmonary capillary pressure, (3)-Decreased oncotic pleural pressure 
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and (4)-lypmphatic obstruction. Varied factors have been implicated in the 
same ranging from localized pathology to systemic causes. This wide spectrum 
of the causes for pleural effusion presents a daunting task to the clinician in 
determining the exact pathology for the same .The initially step in evaluation of 
any pleural effusion is the basic separation into transudative and exudative 
effusions. This is a vital step as once the pleural effusion is found to be 
transudative no specific further management is required and treatment with 
diuretics will suffice as more than 80% of the transudative effusions were due 
to congestive heart failure as stated in a study by Theodoros et al(3). 
However a pleural fluid being exudative further detailed clinical 
methods and further exhaustive work up was necessary to exactly the 
determine cause for any exudative effusion as it goes a long way in the 
management of the same. Pleural effusions as a result of pleural disease more 
closely resembles that of plasma concentration. This is based on the concept 
that any inflammatory condition of the pleural fluid membrane leads to 
increase permeability of the capillaries thereby leading to transport of high 
molecular weight compounds along the concentration gradient.  
While a transudative effusion occurred in the presence of a normal 
pleural membrane which was caused due to hemodynamic or the oncotic 
changes and is an ultrafiltrate of the plasma. The transudation of plasma 
through an intact serous membrane as in transudative effusions leads to 
transport of water and lower molecular weight compounds 
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(sodium,glucose,urea) and at the same time prevents the protein molecules to 
permeate through the intercellular pores of the normal pleural endothelium.  
However a pleural effusion with lymphatic obstruction also lead to a 
high concentration of proteins in the pleural fluid and was an example for an 
exudative effusion with an intact pleural membrane. The most important step in 
discriminating exudates and subcategorizing was to differentiate malignant 
from non malignant effusions. Further on non malignant effusions were 
classified as tubercular or effusions due to bacterial causes.                                                  
Thus over the years various methods for the differentiation of pleural 
effusion was studied and different studies performed varied parameters for 
segregating the same. Historically the initial method for assessing the same was 
via pleural fluid specific gravity. A pleural fluid specific gravity of >3mg/dl 
was considered equivalent to that of pleural fluid proteins.This was used for a 
certain time period for the classification of exudates and transudative pleural 
effusion.  
However the major drawback being this method wrongly classified 
around 30% of the effusions as quoted by  Paddoc FK in 1940.Later on 
Leuallen and Carr  in 1955 in a study comprising 436 patients claimed that 
pleural fluid protein was a better parameter in differentiating pleural effusions. 
This study too had certain drawbacks in the form of misclassification of pleural 
effusions. Further on 14 years later in 1958 Wroblewski, described that pleural 
fluid protein criterion alone was not significant to distinguish pleural effusions 
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and thus stated that pleural fluid protein to serum protein as a more reliable 
criteria for the same .He further observed that pleural fluid LDH of malignant 
effusions were higher than the simultaneous serum LDH level. Following 
which various studies in the subsequent years also quoted that pleural fluid 
LDH can be raised in exudative effusions, however no concrete data was found 
for the same and no study citing the combination of pleural fluid protein to 
serum protein and pleural fluid LDH to serum LDH were found  till 1972. 
In 1972  Light et al(4) studied the corelation between serum LDH to 
pleural fluid LDH and serum protein to pleural fluid protein levels to 
effectively discriminate between transudates and exudates.Lights criteria stated 
as follows 
1. Pleural fluid protein /Serum protein >0.5 
2. Pleural fluid LDH/Serum LDH >0.6 
3. Pleural fluid LDH > 2/3rd of upper limit of serum LDH 
Light et al showed that pleural effusion to be classified as exudates any one 
of the three criteria was to be satisfied and on the other hand a transudative 
effusion met none of the  above mentioned criteria. Lights Criteria stood the 
test of time for nearly four decades and it accurately classified pleural effusions 
and was regarded the very basic step in evaluation of patients with pleural 
effusions.  
Till date Lights criteria is widely accepted as the initial step in the 
management of pleural effusions. However studies done subesequently stated 
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that though Lights criteria had a good sensitivity for classifying exudative 
effusions i.e 98% sensitivity, almost 30% of the transudates were misclassified 
as exudates and analysis of pleural fluid of patients with transudative effusions 
with congestive heart failure post diuretic therapy met the exudative Lights 
criteria.  
Another important drawback of the Lights criteria was that other than 
the initial classification of pleural fluid into exudates and transudates, it failed 
to further sub classify and attach a specific label to exudative effusions. Similar 
studies by Porcel et al(2)  using the standard Lights criteria further confirmed its 
draw backs as in the misclassification of  transudates. Despite these drawbacks 
pleural effusion classification via Lights Criteria still remains the gold standard 
in the initial evaluation of patients. 
Thus in the following years, studies were carried on for the search of 
newer biomarkers for pleural effusion ,and almost all studies concluded that a 
single biomarker was not sufficient for discriminating pleural effusions. A 
direct quote by Richard Light echoed the same which states that “A single 
chemical test or a set of chemical tests is rarely 100% effective in separating 
two sets of populations of pleural effusions, but increasing the number of tests 
results in a reliable seperation” . 
Various  biomarkers were studied subsequently and few reliable ones 
with positive outcomes were as follows. This was in concurence with a study 
by Muzaffer et al(5) were in 93 patients were recruited for the study of which 21 
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were transudatives and 72 were exudatives and studied the following 
parameters for their seperation. Study concluded that  
1. Pleural fluid cholestrol-77% sensitivity 
2. Serum –fluid albumin -67% sensitivity 
3. Pleural fluid/serum alkaline phosphate -83% sensitivity 
4. Pleural creatinine kinase-83% sensitivity 
5. Pleural fluid uric acid- 71% sensitivity 
However of the above mentioned only a pleural fluid cholesterol/serum 
cholesterol and pleural fluid to serum bilirubin and pleural fluid pre albumin 
were statistically significant to the Lights Criteria which were further stuidied 
in detail. Hamm et al(6) in 1987 in a prospective study conducted in Germany, 
studied the importance of pleural fluid protein, pleural fluid LDH and pleural 
fluid cholesterol and examined their investigatory utility in the differentiation 
of transudates and exudates. In the 70 patients enrolled in the study, only 62 
patients had an underlying diagnosis of which 31 were transudates and rest 31 
were exudates.  
Study showed that elevated  pleural fluid cholesterol was independent of 
serum cholesterol levels and further on pleural fluid cholesterol levels when 
used along with the traditional Lights Criteria was an excellent indicator for the 
discrimination of the pleural effusions. 
Results showed that effusions associated with CHF/other transudative 
pleural effusions had a mean cholesterol gradient of 30+/-12mg/dl was 
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statistically significant and malignant effusions had a mean cholesterol gradient 
of 94+/-25 mg/dl (mean range between-62-155).Further on there was no 
overlap between the two study groups.  
They also evaluated the ratio of pleural fluid to serum cholesterol ratio 
in various type of effusions and concluded that both absolute levels of pleural 
fluid cholesterol and concentration ratio were diagnostic indicators for 
separation of pleural effusions when used along with traditional Lights Criteria 
in border line cases. This lead to the origin of Modified Lights Criteria in the 
diagnosis of pleural effusions. Further on the study stated that using a  cut off 
value of 60mg/dL  there was complete separation between transudative and 
exudative effusions and effusions of inflammatory origin had a mean pleural 
fluid cholesterol of 76 mg/dL,transudates had a cut off of 30 mg/dL and the 
pleural fluid cholesterol levels for malignant was 94mg/dL.  
A similar study done by Guleria et al(7) in 2003 in India were in 50 
patients with exudative(25 tubercular,25 non tubercular) and 25 patients of 
transudative effusions were studied .The study concluded that  a mean pleural 
fluid cholesterol of 60 mg/dL ,pleural fluid to serum cholesterol of 0.4 were 
characteristic of exudates and assessing the pleural fluid cholesterol and the 
pleural fluid to serum cholesterol ratio had a sensitivity of 98% and a 
specificity of 100% for exudates and cited that the results yielded were superior  
to Light et al(sensitivity of 92%,specificity-80%) and they concluded stating 
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pleural fluid cholesterol as a simple and cost effective biomarker in 
differentiating an exudate from a transudative effusion.  
Mainly two hypothesis were explained for the diagnostic accuracy of 
pleural fluid cholesterol stating that   
a. Cellular degradation of both WBCs and RBCs as assumed for chylous 
effusions 
b. Serum leakage hypothesis-which explains for high pleural fluid 
cholesterol seen in exudative effusions as a result of increased 
permeability of the pleural membrane. 
However it was noted that chylous effusions also had similar pleural 
fluid cholestrol level, but the actual different ion between chylous effusions and 
exudates were based on the demonstration of chylomicrons and elevated 
Triglycerides in the former. Further on the reliability of pleural fluid 
cholesterol in differentiation of exudative from transudative effuions 
diminished and was loosing its importnace.  
Thus search for other biomarkers continued and in 1990 Simcha et al(8) 
in Israel  demonstrated that pleural fluid to serum bilirubin ratio for the 
separation of transudates from exudates.The study conducted on 51 patients 
concluded that pleural fluid to serum bilirubin ratio helped in differentiation of 
pleural effusions and a ratio of 0.6 or more in the presence of an exudative 
effusion(as met by the Lights criteria) was statistically significant  with good 
sensitvity and specificity  and a positive predictive accuracy, overall  sensitivity 
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being around 90% .Similar  results were found for transudative effusions were 
the pleural fluid to serum bilirubin gradient of 0.6 or less were significant for a 
transudative effusion. Another similar study too proved the efficacy of pleural 
fluid to serum bilirubin  ratio by concluding that  a ratio of 0.6/more had a 
sensitivity of 96.2% for discriminating exudative pleural effsuions. 
Similarly other biomarkers such as Vascular Endothelial Growth Factor 
(VEGF) which is a endothelial biomarker and a net result of angiogenesis were 
further studied  for identification of exudates as increased capillary 
permeability is an important characteristic of an exudative effusion.  Thus 
study for newer biomarkers continued and no single biomarker was found to be 
superior to the traditional Lights Criteria .  
Newer biomarkers were needed for primarily diagnosing the etiology of 
a pleural effusion and to further differentiate a malignant from a non malignant 
effusion.   Porcel et al(2) in a study described an ideal biomarker as one which  
can be defined  as  a biological  molecule  that is found in blood  ,other  body  
fluids  or tissues  that  is a sign of  a normal  or an abnormal process  or  of a 
condition or a disease such as malignancy, infection  or heart failure. He further 
on stated that an  ideal  biomarker  as  one which  can be measured easily at a 
reasonable  cost (analytical validity),  should provide  information  which is  
new and  is  not  already available  from a  routine  clinical assessment (clinical 
validity) and finally should be  helpful in aiding the clinical diagnosis( clinical 
usefulness). Thus  the  search  for this ideal  biomarker  ensued  and studies for 
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the same concurrently started thus gradually moving beyond the  Lights  
Criteria 
  As per  the  Infectious Disease Biomarker Data  approximately  around 
611  biomarkers  were  involved for  66 Infectious Diseases and  70  pathogens, 
that  was roughly estimated to be  8-9  bio marker / pathogen. Thus amongst 
this varied  biomarkers available it was  needed to estimate  the most reliable 
biomarker in the suitable setting given the limited resources available for the 
same.  The following studies stated were in view of identifying the best 
biomarker in  each type of effusion.  
Bielsa S et al(9)  in a  study involving  cardiac and hepatic transudates 
analyzed the role of  pleural fluid to serum protein, LDH  and albumin 
concentrations   in  364  cardiac effusions  and  102 Hepatic transudates which  
concluded that   heart failure  related transudates were more often misclassified 
by Lights Criteria than  hepatic transudates(29% to  18% ,p=0.002).Similarly  
an  albumin gradient  of >1.2 g/dL  had a  sensitivity of  83% for  cardiac 
transudates  and  62%  for hepatic transudates. The  study  concluded  that  in  
the setting  consistent  with  heart  failure ,  the  pleural  fluid meets  the  Lights  
criteria , measuring  the  albumin  gradient  than   the  protein  gradient  is  
considered the  best.  
Similar  other  studies  were   carried  out  to  classify  the  wrongly  mis 
placed  cardiac transudates as per the Lights criteria  were  in  post  diuretic  
therapy  the  cardiac  transudates  met  the  criteria for  exudates as  per Lights  
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Criteria  by   a narrow  margin. Amongst  this  the  vastly  studied  biomarkers  
were  Natriuretic Peptides which  included the Brain Natriuretic Peptide  and  
the  amino terminal fragment  ie; NT proBNP and  the   mid regional  pro atrial  
natriuretic peptide(MR-pro ANP).  Natriuretic  peptides  are defined  as  those  
neurohormones  which in response to increased  pressure  in the  hear chambers  
are  secreted  by the cardiomyocytes.   
Initial  study  in 2004  by  Porcel  al(2)  analyzed  its  usefulness and  
concluded  that  measurement  of  NT  pro BNP  and  BNP  helped  in  
differentiating  cases  of effusion caused  by  heart  failure.  Further on  it  
stated  that  a  serum  level  of  BNP > 500 pg/mL  and  serum  level  of 450-
1800pg/mL of NT  pro BNP  were  highly  suggestive  of  heart failure  in an  
acute  setting.  Since  2004 various  other  studies  have  analyzed  the  
importance  of  BNP and NT pro BNP  and  in  meta analysis  of  10  studies  
which  included  429  cardiac  and  691  non  cardiac  patients    a  combined  
sensitivity  and  specificity  of  94%  was  observed  and  a  value  of  >1500 
pg/ml  for  NT pro BNP  confirmed  heart  failure.  
Measurements  of  pleural  fluid  MR  pro ANP  was studied to have  
properties similar to that  of  NT pro BNP. Further  on  in  those  80%  of HF  
associated effusions  which  were  misclassified based  on Lights criteria,NT  
pro BNP  evaluation was found to be superior to BNP. Thus  calculation  of NT 
pro BNP values  were found  to be  significant  in the  clinical suspicion  of 
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effusion due to  heart  failure were  other  methods  failed  to give  a diagnostic  
accuracy for the same. 
Similarly  newer  biomarkers  were  studied  for  infectious  
effusions(non tubercular  effusions)  as  this  presented  a varied  list of causes 
for the same. Thus it was  of  great  difficulty  to  identify  accurately  the  
precise  biomarker  which can pin point  the  accurate  nature  of  an infectious  
effusion. Inflammatory  effusions  were  initially  divided  based on  the  
duration  to  acute, sub acute and chronic. 
Acute conditions  begins  immediately  and lasted  for  a few  days, 
while  sub acute  and chronic  effusions  had  an insidious  process and lasted  
for months together. It  was  proved  that  in the  initial  stages(ie-acute 
infection)  a combination  of  neutrophil predominant pleural fluid cytology  
with a low  pleural  fluid  glucose(<40 mg/dL) and low pleural fluid pH(<7.2)  
were  indicators  for an acute  infection along  with  the presence  of  band 
forms in peripheral  smear. 
This  has  been  related  to the  hypothesis  which  states  that  in an 
acute  type of  pleural injury  initially neutrophils  were  attracted  to  the 
pleural  space  by  the  production  of  chemo tactic factor that  is  Interlukin 
8(IL8)  ,as  the  nature  of  the  illness  progresses  this  neutrophil  
predominance  was  replaced  by  an lymphocytic  exudate   which  yielded a  
diagnosis  of  sub acute  or  chronic  inflammatory  pathology.  Certain  other  
biological  parameters  were  also  studied by Hassan et al(10)  to  differentiate  
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an  acute  presentation  from  an  sub acute  presentation  which  included  
soluble  triggering receptor expressed  on  myeloid  cells  (STREM-1),  lipo 
polysaccharide binding  protein(LBP), C reactive  protein(CRP),tumor  
necrosis  factor(TNF alpha) ,myeloperoxidase  of>3000microgm/L  , matrix  
mettalloproteinase  2  </equal  to  343 ng/ml  ,neutrophil elastase  , interleukin 
8 etc. Each  biomarker  reflected  the  different stages  of  an  inflammatory  
process    and  were  easily  measured  by  immuno assays.   
In  a  study  by  Theodoros  et  al(3)  in 2006  analyzing  the various  
biomarkers  for  infectious  effsuion  concluded  that  CRP, IL6  and TNF alpha  
measurements  gave  an accurate  diagnosis in the  setting  of  a parapneumonic  
effusion.  Other  studies  by   Perlat  et  al(11)  analyzing  the  biomarkers  of  
acute  inflammation  stated  that  a pleural  fluid  CRP  of >30mg/L  had  
diagnostic  evidence  towards  parapneumonic  effusions.  Another  prospective  
study  by  MG Alexandrakis  et  al  in(12) Greece  in  2000  analyzed  the  
importance  of  alpha 2 macroglobulin  and  alpha  1 acid  glycoprotein  in 
differentiation of pleural fluid  and  suggested  that  both  AAG  and  AMG  
were  significantly  higher  in the  exudative  group.   
Further  on  differentiation  between  complicated parapneumonic  
effusion  and  un complicated  parapneumonic  effusions  were  needed, as  a 
CPPE  required a tube  thoracostomy. Skouras V et al(13)  in a study  conducted  
over  54  patients  in Greece  were in  23  patients had CPPE and  analysis  of  
pleural  fluid  CRP  of >  78.5  mg/L  and  a serum CRP  of  >83mg/L  gave  a 
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sensitivity and  specificity  of  65%  and  87%  respectively. Further  on they 
stated  that  a serum CRP >150 mg/L  had a 91%  specificity  and  61% 
sensitivity  for  prediction of  a  residual  pleural  thickening(RPT). 
The  study  concluded  that  pleural  fluid  CRP  and serum CRP  when  
used  along  with  the traditional  Lights criteria  had  a role  in differentiating 
complicated  parapneumonic  effusions  from the  non complicated 
parapneumonic  effusions.  Further  other  tests  of less significance  have  been  
studied  in  a  background  of  low  income settings which  stated  the  use  of    
Leukocyte Esterase Reagent Strips. A study  tested  its  efficacy  in  42  patients  
with  bacterial  infections,  15  with  tuberculosis  and in  71  patients  with  non 
infectious  causes  which  stated  that   a  positive test  yielded  42 % sensitivity  
and  100%  specificity. 
 Similarly another  studied  biomarker  in  similar settings  of  the  
previous  study  was  the Rapid Pneumococcal  Antigen  Test which  was found 
to  be positive in cases of pneumococcal pneumonia complicating with  
effusion(71% sensitivity).However  the  clinical reliability  of this  test  was  
not significant to  discriminate  infectious  from  non infectious  causes. 
Tubercular  effusions  was  responsible  for  nearly  50%  of all cases  of 
effusions in an  endemic  country like  India. Thus  the  correct identification 
and early treatment  of  a  tubercular  effusion helped  in preventing  the  
mortality  and  morbidity  due to  the  same. The  need  for  newer  biomarkers  
exclusively  for  tuberculosis  were  due to  the  fact  that  the  conventional  
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methods  for  the  same  were  time  consuming  and  concurrently  the  yeild  
was  low.  
They  included  the  identification  of  mycobacterium  tuberculosis  in  
pleural  fluid  and this  was  further  complicated  by  the low yield  for  the  
same. In  retrospective  analysis  of  214  patients  with  pleural  tuberculosis  
the  conventional  solid  culture  media  for  mycobacterium  were  just positive 
in only  28% of the sputum samples  and was further  low in pleural fluid 
samples(around 15%), further on AFB staining  which is  considered as  more 
rapid diagnostic method  had  a sensitivity (14%)  and specificity of 3%. 
Further  the  demonstration  of  granulomas by  pleural biopsy was found to 
confirm diagnosis in around 80% of cases  but  due to  the  invassiness of  the  
procedure  and  the  dependence  of  the  operator skills  it was also  considered 
as  less likely diagnostic method for the same.  
This  further  increased  the urgent  need  for  a  novel  biomarker  for  
tubercular  effusions  which  was  easily reproducible less expensive  and  non  
invasive.  This  led  to  the  study of adenosine deaminase, interferon gamma  
for  the  same. Further  a raised  lymphocytic  effusion  in  the  presence  of 
raised  ADA(>40 )  with  clinical  features  were  considered  suggestive  for  
tuberculosis  in an endemic country like India.  In  a study  by  Porcel et al(14), 
Jiemenez DC et al(36) ADA  levels were evaluated  in the pleural fluid of 2104  
patients  in whom  221  had  tubercular  effusion.  
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The pleural fluid ADA level were > 35 U/L in 93 % of the cases.  
However the study concluded that a very high ADA (>250 U/L) were  
significant of  empymas rather  than  tubercular effusions.  The  ADA  
molecule  occurs  in  mainly  2 isoenzyme  forms  that  is  ADA 1  and  ADA 2.   
ADA  1  is  found  to  be  commonly seen in  all cells while ADA 2 is  
specifically  isolated from patients  with  tubercular  effusions  and  is  found  
to  be  elevated. 
 In a  meta analysis  of  63 studies, ADA  was  reported to have  a  
sensitivity  of  92%  and specificity of 90 %.  Thus  the  measurement  of  ADA  
along  with  clinical features  was concluded to have an  excellent diagnostic  
value  with  a sensitivity  and  specificity  rates  of  95% and 97% respectively.  
Interferon gamma  which is cytokine which is  derived from  lymphocytes  has  
also  been  studied  in  the  diagnosis  of tubercular  effusions . 
However  the  sensitivity  and specificity  of this  biomarker  was  found  
inferior  to ADA  measurements. But  when combined  along  with  the  routine  
clinical parameters  it yielded  a  sensitivity of  96%  and specificity of  93%  
which  was quoted  in a study  by  Greco  2003. Other  studies  such  as  the  
commercially available  QUANTIFERON TB GOLD, T SPOT TB were  found  
to  be  poor  biomarkers  when  compared  to  interferon gamma assay.   
The  nucleic acid amplification and detection of mycobacterium 
tuberculosis  in pleural fluid have yielded  a  specificity  of 95%  and  
sensitivity of 60%.However  it  is  not of significance. 
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Malignant  effusions  account  for nearly 40-60% of all types of pleural  
effusions globally and the  diagnosis  of  a  malignant  effusion is  established 
by the presence of  malignant  or  atypical  cells  in pleural  space .But  the  
pleural fluid cytology  has been found to be positive in only 60% of the cases 
and it is said  that  at least  a large amount of  pleural fluid to be necessary for a 
confirmatory diagnostic yield.  
Further on confirming  the  presence of  a  malignant tissue via  biopsy 
has a sensitivity of 80% in clinching the diagnosis, but owing to the invasiness 
of  the procedure and  the skills of the operator  it is found to be less significant 
in limited resource settings. These made the need for newer biomarkers for 
diagnosis of  malignant pleural effusions.  
The following  bio markers  were  studied  which was described in a 
metanalysis of 45 studies, which included  2834 patients with malignant and 
3251 patients with non malignant effusions and it summarized that  pleural 
fluid CEA  as  a biomarker had a sensitivity of 54 % and specificity of 
94%.Other biomarkers  studied in the respective met analysis were  CA 125,  
CA  15-3,  CA 19-9, cytokeratin fragment(CYFRA).Further on  high pleural 
fluid CA 125  was  found to be observed in  squamous and adenocarcinomas 
and  had  a  poor  prognostic  role.  
Pleural fluid CEA  was  on  of  the  first  biomarkers  to  be studied  for  
malignant pleural  effusions  and  was  specifically  elevated  for  metastatic  
adenocarcinomas  and   had  a  prognostic significance  in terms  of  median  
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survival  and treatment response.  CYFRA 21  a  cytokeratin has  found to have  
a  role  in  both  prognostic as  well  as  diagnostic  role  in  non small cell lung 
cancers  which  was studied in  prospective study  by Wagner  in Spain. 
malignant pleural  effusion was found to be seen in approximately  50% of the 
cases  with  lung cancer.  
Further on the diagnosis of mesothelioma related pleural effusions  were  
difficult as the number  of studies were few. However the  identification of  
pleural fluid mesothelin  was found to be significant for the same. Other  
biomarkers for diagnosis of malignant pleural  effusions  included  soluble 
mesothelin receptor protein(SMRP) which is significant of mesotheliomas. 
Immunohistochemistry was also performed on cytological pleural fluid samples 
and the following immunohistochemical markers were found to be significant 
which included Thyroid transcription factor 1 (TTF1) for differentiating 
epithelial mesothelioma from adenocarcinoma, desmin, calretnin,  CK 5/6, 
MOC 31 ,WT 1 ,Napsin A, BG8(Lewis) were the other studied 
immunohistochemical markers in pleura fluid cytology. It is  said that when 
used in together with routine pleural fluid parameters, the biomakers for 
malignant pleural effusion assumed significance. Also other molecular tests 
like fluorescent insitu hybridization (FISH),  gene expression have found to aid 
and improve the cytological diagnosis of the same and is yet   to  be included  
in routine  clinical  practice. 
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Among all the  varied  biochemical markers analyzed in the setting of 
pleural fluid analysis along with  traditional Lights criteria only a few  
biomarkers  have  shown to  be  promising as  a reliable  biomarker  in  the  
near future  and of  the  following  included  C reactive  protein (CRP)  which  
has  been  studied in the back drop of various  clinical settings  and various 
etiologies of pleural  effusion. It was found  to be a simple and  cost effective 
method  for  classification of pleural effusions and also  further aided in the  
separation  of  malignant from non malignant effusions. Due to these above 
mentioned characteristics , pleural fluid CRP  measurement  was  studied in 
detail . 
As  the  clinical  symptoms were overlapping and  with other constraints  
such  as  lack  of specificity  of  pleural  fluid cultures and  increase  turn  
around time, it was important  to  study  one particular  biomarker which can be  
helpful in the above setting. CRP  is  an  acute  phase  protein  which  is  
synthesized  in  the  hepatocytes  in the  back ground  of  an inflammatory  
setting. It is  helpful  in  monitoring  changes in any  inflammatory  condition  
such  as trauma,  malignancy  which  are  the  usual  inflammatory  scenarios 
seen in  an hospital setting.  
The increase in CRP  in these conditions is  mainly  due to  the  
production  of  Interlukin 6(IL 6)  which is  in turn  released  by  the   activation  
of  macrophages  and  adipocytes  as  a  result  of  immune  stimulation. CRP  
plays a key  role  in inflammatory  process  by  binding to  phosphocholine  on  
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the  microbial  organisms  and  thereby  leading to  its  intracellular destruction  
by  macrophages. Further  CRP  also  activates  the  complement  system via  
the  C1q  complex .Thus  it  is  said  that  CRP  is  an effective  initiator  of  an  
inflammatory  reaction  in  the  body, thereby  significantly  adding  to  its  
weight age  in  determining  the  disease  progression and   effectiveness in  its  
treatment.  
These  characteristics  of  CRP  coupled  with  ease  of investigation  
and  the diagnostic reliability of the test  made it a biomarker of choice for the 
differentiation of pleural effusions. Numerous studies worldwide have 
supported the use of pleural fluid CRP as a useful adjunct in the differentiation 
of pleural effusions. 
Sanjose et al(15)  in a large prospective study conducted in 2002  in 233 
patients with pleural effusion evaluated the clinical significance of pleural fluid 
CRP.Of the 233 patients studied  they were further sub divided into  5 groups 
as  Parapneumonic(28 cases), Tubercular(n=49), Malignant(N=57), Traumatic 
(n=53) and  Mixed etiology(n=46).Study concluded that  pleural  fluid CRP  
was higher  in the  parapneumonic group  as  compared  to that  of  other  
groups(with a stastical significance  of  p<0.0001) also  low  levels of  CRP  
were  significant  in  the  malignant  and miscellaneous group  with  a P value 
between 0.001-0.004. 
In another  cross sectional  study  done  on 166  patients  with  pleural 
effusion in 2005 in Thailand  they  studied  the  clinical use fullness of  and  the 
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validity  of  ratio  of pleural fluid to serum CRP  in  the  differentiation  of  
tubercular  from malignant  effusions  in  a back ground  of  lymphocytic 
exudative effusions.Of the  148 patients with lymphocytic exudative effusion , 
55  were  tubercular  effusions,60 were malignant effusions  and 33 effusions 
were of unknown etiology. The study  concluded  that  the  ratio  of pleural 
fluid to serum CRP were  higher in  tubercular  than in malignant pleural 
effusion(54.58 4.5mg/L and 106.93  9.54 mg/L with  a  P <0.001) and that 
the ratio  of pleural fluid to serum CRP  was  higher in the  tubercular  group  
as  compared to the malignant group . 
A cut off value  for  pleural fluid CRP>30 mg/dL  had  a sensitivity  of  
72% and a specificity of 93%  and  a pleura fluid to serum CRP  ratio of 0.45 
had a sensitivity of 60%  and  specificity of 89%  in differentiating tubercular 
effusions from the malignant counterparts.   
Yadav et  al(16)  in  a study  conducted on  187 patients with exudative 
pleural effusions  concluded that  pleural fluid CRP  can be used as a diagnostic 
tool in specifically differentiating  effusions  of acute  and chronic  origin  as  
well as  differentiating  infectious  from  non  infectious  group  and  suggested  
that  a pleural fluid CRP value >30 mg/L  excluded malignant effusion .Patients  
included  in the study were categorized into 5 groups  which were malignant, 
chronic non specific inflammation, parapneumonic effusions, tubercular pleural 
effusions and  miscellaneous group.  
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In differentiating tubercular effusions from non tubercular effusions  
pleural fluid CRP had  a good sensitivity of  97.05% and a specificity of 
71.76%.Similarly for differentiating parapneumonic from malignant effusions, 
pleural fluid CRP had a sensitivity of 100% and a specificity of 98%.  
Hoda Abu et al(17) in a study in Egypt in 2010 highlighted the 
importance of  the diagnostic value of pleural fluid CRP  in  the etiological 
diagnosis of pleural effusion and concluded that  pleural fluid CRPs were 
higher in tuberculosis than malignant effusions than that in parapenumonic 
effusions and the lowest for a transudative effusion. The study  included  10 
patients with transudative pleural effusion,  12 patients with tubercular 
effusions,14 patients with malignant pleural effusions and 4 patients with 
bacterial parapneumonic effusions.   
Huang et  al(18) in a study conducted amongst  209 patients with pleural 
effusion evaluated the diagnostic significance of pleural efuid CRP and pre 
albumin in the differential diagnosis of infectious from malignant effusions, 
concluded that pleural fluid pre albumin levels were high in malignant 
effusions as compared to parapneumonic effusions and the combination of 
pleural fluid pre albumin and pleural efluid CRP had a combined sensitivity of 
61.7% and specificity of 90.3%.  
Garcia  et al(19)  studied the  importance of  pleural fluid CRP in 
lymphocytic pleural effusions and  evaluated its significance in the diagnosis of 
tubercular effusions. 144 patients with lymphocytic predominant pleural 
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effusion  were recruited  of which  93 were men and 51 were women ,further 
classified the lymphocytic effusion of which 20 were tubercular  and   69 were  
malignant effusions  and transudates and other benign exudates formed  other  
55 effusions .Conclusion of the study was that  pleural fluid CRP  was higher in 
patients of tubercular effusion (54 +/-24mg/l) than compared to  lymphocytic 
effusions of other origin (21 +/- 16 mg/l,p<0.001).The study also stated that 
high pleural fluid CRP (>/=50mg/L) had a high specificity for tuberculosis and  
low levels(<30 mg/L)  had a high sensitivity for excluding tubercular effusions. 
As most of the studies  applied pleural fluid CRP in the differentiation 
of parapneumonic effusions ,its similar  beneficial effects for discrimination of 
malignant effusions were also studied through various trials. The importance of 
raised pleural fluid CRP in malignant effusions lies in the fact that  a malignant 
condition  is  basically an inflammatory condition were in various mediators of 
inflammation are released  which in turn increased CRP levels .Also  increased  
production of cytokines  by  the tumor tissue was responsible for increased 
CRP production which was another  hypothesis which correlated the 
importance of CRP analysis in malignant effusions.  
Scott et al(21)  in a  publication in the year 2002   highlighted  the 
importance  of  the  catabolic  effects of  CRP on metabolism and stated that  
increased  CRP  in  a malignant state was involved in  increase in resting 
energy expenditure  and loss of fat free mass in patients with carcinoma which 
were in turn key factors for determining cancer survival  and in these sub set of 
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patients no significant  difference was found in the total counts  ,frequency of  
bacterial culture growth in pleural fluid samples  and  in sputum samples 
between the  high  and the low pleural fluid CRP patients indicating that  raised 
CRP  is not an indicator of infection alone. 
Park et al(20)  in a study conducted in 2012  in Korea  evaluated  the 
diagnostic and prognostic  significance of CRP in lung cancer patients with 
pleural effusions. A total  68 patients  were  recruited for  the study   and the 
pleural fluid to serum ratio of CRP was evaluated. It showed that  
differentiating malignant from infectious effusions  pleural fluid CRP was of 
greater significance than serum CRP and higher pleural fluid CRP levels 
correlated with  shorter over all survival time(p=0.006).Over all the study 
concluded that  the evaluation of pleural fluid CRP superior to serum CRP in 
cases of malignant effusions and the quantitative measurement of  pleural fluid 
CRP helped in predicting the over all survival out come in lung cancer patient 
and stated that  the  risk  of death  for lung cancer  patients with a high CRP 
was 3.909(95% confidence interval).                                                                                  
Nusarth et al(22) in a study conducted among  100 patients  showed that 
pleural fluid CRP analysis could differentiate transudate from an exudative 
effusion and further on pleural fluid CRP helped to differentiate inflammatory 
from non inflammatory effusions. Study concluded that a mean CRP 
of>6mg/dl,was significant for a parapneumonic effusion, patients of tubercular 
effusion had CRP>2mg/dl and pleural fluid CRP for malignant and 
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transudative effusion was <2mg/dl. Further on gross appearance of the pleural 
fluid like hemorrhagic(malignant, embolism),milky white(lymphatic duct 
obstruction),straw colored(tubercular effusions) also helps in some extent in 
diffrentiating the varied causes of effusions.  
Castano et al(23) in a study comprising 72 patients proved that high 
pleural fluid CRP as an accurate method of differentiating parapneumonic 
effusions from other effusions. Further on malignant effusions were proved by 
the demonstration of atypical cells in pleural fluid ,or via the demonstration of 
malignant tissue in a biopsy specimen. Tubercular effusions were 
predominantly exudative with lymphocytic cells and presence of mesothelial 
cells along with presence of clinical features such as cough ,fever which aids in 
the clinical diagnosis of tubercular effusions. Parapneumonic effusions were 
highly exudative with neutrophil predominance and pleural fluid cytology 
negative for malignant cells and patients had a positive response to antibiotic 
therapy. 
Alexandra et al(12) in a study comprising 84 patients of which 65 were 
exudates,of which 27 were malignant and 23 were of infectious etiology and 19 
were transudative.In the 65 exudative effusions(46 were men,19 were women 
with a mean age of 60 years,in the transudative group of 19,12 were males and 
7 were females with a mean age of 70 years).This study concluded that 
exudative effusions had a significantly higher CRP than transudative effusions 
and CRP>1mg/dl had a good sensitivity and specificity for differentiating 
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transudates from exudates .Study also showed that pleural fluid CRP was a 
useful marker when used along with the Lights criteria in the diagnosis of 
border line cases.   
Waffa et a1(24)   in a study conducted on 100 patients correlated the 
value of pleural fluid CRP  with the nature of the effusion and concluded that a 
mean pleural fluid CRP of 0.4-2 was suggestive of a transudative 
effusion,while a parapneumonic effusion had a higher range of pleural fluid 
CRP levels ranging from 1.8-20,tubercular effusions had a CRP between 1.01-
6.8,thereby concluding that higher values of pleural fluid CRP was significant 
for pleural effusions of inflammatory causes(i.e parapneumonic and 
tubercular),while lower CRP levels were significant of malignant and 
transudative  effusions. 
Thus  from the  above mentioned  studies it was noted that  pleural fluid 
CRP as a reliable indicator  for the differentiation of both malignant as well as 
non malignant pleural effusions(parapneumonic)  and when used along with the 
Lights Criteria had a good specificity and sensitivity for separation of the 
pleural effusions and it ranked  above  other biomarkers studied in terms of  its 
clinical utility to a clinch a diagnosis and being cost effective and a simple test. 
However the limitation of pleural fluid CRP being in its inability to separate 
transudates and also  the inability of the pleural fluid CRP in differentiating 
tubercular from malignant effusions from the parapneumonic variant was also 
noted as another drawback . 
39 
 
Despite these important drawbacks of pleural fluid CRP it has shown 
promising  outcomes in the  differentiation of parapneumonic pleural effusions 
in research trials  and the same has to be replicated in routine clinical practice 
and is hopeful of the same in the near future. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Results 
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RESULTS 
We  present our study results under  the following description 
1. Distribution of study variables 
2. Comparison  of the variables between transudative and exudative 
effusions 
3. Comparison of the variables between  exudative effusions of varying 
etiology 
A. DISTRIBUTION OF STUDY VARIABLES: 
Sixty subjects were recruited in our study. Out of the sixty subjects 39 
were males as compared to 21 female study participants(65 and 35 % 
respectively). The age of the study participants ranged from 30-80 years of age 
with a mean of  52.85 ±17.77 years with a mean BMI of 25.38±1.54 kg/m2.Off 
the sixty study subjects 54 consumed mixed diet(90%).In the sixty subjects 
studied, 24 had a history of smoking(40%) while 10 had a history of alcohol 
consumption(16.7%) 
  Symptamatology studied amongst the sixty subjects revealed that 
majority of the subjects presented with breathlesness(41,68.3%) and cough 
(41,68.3%) as the cardinal symptoms,chest pain was seen in 19 patients with 
pleural effusion(31.7%),followed by fever which was noticed in 20 patients at 
33.3%  followed by hemoptysis which was seen only in 2 cases(3.3%)Amongst 
the comorbdities studied in the sixty study subjects, Diabetes Mellitus was seen 
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in 20 cases(33.3%),followed by systemic hypertension(13 ,21.7%),coronary 
artery disease seen in 11 cases(18.3%) and COPD and renal impairment 
contributed to seven cases each amongst the study subjcets(11.7%) as 
demonstrated in (Table 1) 
Table 1 This table compares the sociodemographic and clinical 
variables between subjects with transudative and exudative effusions 
 
 
 
 
Sociodemographic and  clinical variables N=60 
Age (in years) 52.85 ±17.77 
Gender –Males   
BMI (kg/m2)                                                                                                                  
39 (65%) 
25.38 ±1.54 
Socioeconomic status (Family Income in 
Rs) 
6050 ±3307 
Mixed Diet 54(90%) 
Smoking status(current /past) 24(40%) 
Alcohol intake(current/past) 10(16.7%) 
Symptoms 
                                   Breathlesness 
                                    Cough 
                                    Fever 
                                    Chest Pain 
                                    Hemoptysis 
 
41(68.3%) 
41(68.3%) 
20(33.3%) 
19(31.7%) 
2(3.3%) 
Comorbid  condition 
                                         COPD 
                                         DiabetesMellitus 
                                         Systemic                                                  
Hypertension 
                      Coronary Artery Disease 
                        Renal  Disease 
                                           
 
7(11.7%) 
20(33.3%) 
13(21.7%)
 
11(18.3%) 
7(11.7%) 
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COMPARISION OF STUDY PARTICIPANTS IN 
TRANSUDATIVE  AND EXUDATIVE GROUP 
 
FIG 1 : This chart compares the number of study participants in 
transudative and exudative group 
 
 
  
n =13
n = 47
Transudates 
Exudates 
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COMPARISION OF BMI IN SUBJECTS WITH TRANSUDATIVE 
AND EXUDATIVE EFFUSIONS 
 
Table 2 : This table compares the BMI (Kg/m2) in subjects with 
transudative and exudative effusions 
EFFUSION TYPE BMI(Kg/m2) 
TRANSUDATIVE 25.95+_1.51 
EXUDATIVE 25.22+_1.52 
There was no stastical difference noted in the age group of the study 
participants in each group with the mean BMI in the transudative group 
being(25.95±1.51) and the mean BMI in the exudative group 
being(25.22±1.52) with a p value of 0.134.None of our study population 
belonged to the obese category.  
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COMPARISION OF THE AGE AND GENDER DISTRIBUTION 
AMONGST THE STUDY GROUP 
 
Table 3 : This table compares the age and gender distribution 
amongst the study group 
TYPE OF EFFUSION AGE/GENDER 
TRANSUDATIVE 59.6216.50/  7 –MALES 
6-FEMALES 
EXUDATIVE 50.9817.80 /  32-MALES 
15-FEMALES 
The mean age group of the patients in the transudative group was 
59.62±16.50 years ,the mean age group of the patients in the exudative group 
was 50.98±17.80 years.).In the transudative group , seven were males and six 
were female participants(53.8% and 46.2% respectively).In the exudative arm 
off the 47 study participants,32 were males and 15 were females(68.1% and 
31.9% respectively).There was no statistical significance between the age and 
gender distribution for transudative and exudative groups(P=0.122 and 0.34 
respectively) 
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 SMOKING  STATUS  AND  ALCOHOL  INTAKE: 
 Table 4 : This table compares the alcohol and smoking status 
between the transudative and exudative effusions 
EFFUSION TYPE ALCOHOL SMOKING 
TRANSUDATIVE 4 20 
EXUDATIVE 1 9 
 
In  the transudative and exudative effusions, when smoking and alcohol intake 
was calculated,there was no significant difference between the two groups and 
no significant correlation was found on the same.The total number of smokers 
in the transudative group were 4(30.8%),and only 1 person had a history of 
alcohol consumption in the transudative group(7.7%) which had no statistical 
significance(P=0.443).Similary when smoking history was reviewd in the 
exudative group 20 of the 47 study participants were smokers(42.6%) while 
there 9 study participants with history of alcohol intake amongst the 47 
exudative effusions(19.1%) which again had no statistical 
significance(P=0.327) 
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COMPARISION OF THE SOCIO DEMOGRAPHIC VARIABLES 
IN THE STUDY GROUP WITH P VALUE  
 
Table 5  : This table compares  the socio demographic variables in the 
study group 
SOCIO 
DEMOGRAPHIC 
VARIABLES 
TRANSUDATIVE 
EFFUSIONS(N=13) 
EXUDATIVE 
EFFUSIONS(N=47) 
P  
VALUE 
AGE(YEARS) 59.62±16.50 50.98±17.80 0.122 
GENDER(MALES) 7(53.85) 32(68.1%) 0.341 
BMI(KG/M2) 25.95±1.51 25.22±1.52 0.134 
SMOKING 
STATUS 
4(30.8%) 20(42.6%) 0.443 
ALCOHOL 1(7.7%) 9(19.1%) 0.327 
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This table compares  the clinical variables(symptoms) between the 
exudative and transudative effusions 
Table 6  
 
 
 
 
 
 
 
In the exudative and transudative arms studied,  breathlesness was the 
predominant symptom seen in 9 of the 13 study participants in the transudative 
group(69.2%) followed by cough(6, 46.2%), chest pain(4,30.8%),fever(1,7.7%) 
.In the exudative group  cough was seen in majority of the 
patients(35,74.5%),followed by breathlesness (32, 68.1%), fever(19,40.4%), 
chest pain(15,31.9%) and hemoptysis in 2 cases.There was no statistical 
significance between the symptoms and the nature of the effusion. 
 
 
SYMPTOMS TRANSUDATIVE EXUDATIVE 
COUGH 6 35 
BREATHLESNSESS 9 32 
CHESTPAIN 4 15 
FEVER 1 19 
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 COMORBIDITIES 
 Table 7 :  This table depicts the relation between comorbdities and  
exudative and transudative effusions 
CO MORBID CONDITION TRANSUDATIVE EXUDATIVE 
COPD 0 7 
DM 8 12 
SHT 7 8 
CAD 8 3 
RENAL DISEASE 5 2 
 
Comorbdities had a statistical significance in transudative effusion  as 
compared to an exudative effusion.Off the comorbid conditions in the 13 
transudative study participants,8 had coronary artery 
disease(61.5%,p=0.0001),followed by diabetes mellitus(8,61.5%,p=0.015), 
systemic hypertension(53.8%,7) and renal disorder seen in 5 cases(38.5%).In 
the exudative group comorbdities played no role in the disease out come and 
was not statistically significant.Thus there was possitive correlation between 
comorbidities and a transudative effusion. 
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CLINICAL SYMPTOMATOLGY  
Table 9  : This table compares the clinical variables in the  study 
group 
SYMPTOMS 
 
BREATHLESNESS 
CHEST PAIN 
COUGH 
FEVER 
HEMOPTYSIS 
TRANSUDATIVE 
 
9(69.2%) 
4(30.8%) 
6(46.2%) 
1(7.7%) 
0 
EXUDATIVE 
 
32(68.1%) 
15(31.9%) 
35(74.5%) 
19(40.4%) 
2(4.3%) 
P  VALUE 
 
0.957 
0.937 
0.052 
0.027 
0.449 
CO MORBID 
CONDITIONS 
 
COPD 
DM 
HTN 
CAD 
RENAL 
 
 
 
0 
8(61.5%) 
7(53.8%) 
8(61.5%) 
5(38.5%) 
 
 
 
 
7(14.9%) 
12(25.5%) 
8(12.8%) 
3(6.4%) 
2(4.3%) 
 
 
 
0.139 
0.015 
0.001 
0.0001 
0.001 
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COMPARISION OF THE HEMATOLOGICAL VARIABLES  
BETWEEN SUBJECTS WITH TRANSUDATIVE AND 
EXUDATIVE EFFUSIONS 
 
Table 10 : This table compares the hematological variables  between 
subjects with transudative and exudative effusions 
HEMATOLOGICAL 
VARIABLES 
TRANUSDATIVE 
EFFUSION(n=13) 
EXUDATIVE 
EFFUSIONS(n=47) 
P 
VALUE 
HEMOGLOBIN(Mg/dl) 9.64±1.69 11.37 ±2.51 0.023 
TOTAL  LEUCOCYTE 
COUNTS (per mm3) 
9746±2641 13,289±12070 0.30 
PLATELETS 2,35,620±87,602 31,3530±128618 0.045 
ESR(mm) 41.54±15.88 60.28±32.14 0.006 
On comparison of hematological variables between the exudative and 
the transudative group, only ESR was found to be statistically significant 
between the two study groups,with a mean ESR of (60.28±32.14) in exudative 
effusions and a mean of (41.54±15.88) in transudative effusions with a P value 
<0.006.Exudative effusions being an condition of intense inflammation,ESR 
was expected to be higher in the exudative group. 
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COMPARISION OF THE BIOCHEMICAL VALUES BETWEEN 
EXUDATIVE AND TRANSUDATIVE EFFUSIONS 
Table 11 : This table  compares the  biochemical values between 
exudative and transudative effusions 
BICHEMICAL 
VALUES 
TRANSUDATIVE EXUDATIVE 
TOTAL  PROTEINS 6.23+_0.74 6.75+_0.55 
ALBUMIN 3.13+_0.39 3.33+_0.50 
GLOBULIN 2.99+_0.48 3.41+_0.44 
 
It is found that serum globulin had a postive correlation in seperating 
transudates and exudates with a mean serum globulin of (2.99±0.48) for 
transudative effusions and a mean serum globulin of(3.41±0.44) for exudative 
effusions with a P value of 0.005.Serum proteins and serum albumin was found 
to have no statistical significance in differentiating between the two study arms 
Thus in comparing the both the biochemical and the hematological 
parameters, It was found through our study that only ESR with a P value 0.006 
and serum globulin with a P value of 0.005  were  statistically significant in 
differentiating exudates from transudates. 
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COMPARISION OF THE   PLEURAL FLUID  PROTEINS 
BETWEEN THE TRANSUDATIVE AND EXUDATIVE 
EFFUSIONS. 
Table 12 : This table compares the pleural fluid  characterstics  
between the transudative and exudative effusions. 
PLEURAL FLUID 
CHARACTERSTICS 
TRANSUDATIVE EXUDATIVE 
PLEURAL FLUID 
PROTEINS(mg/DL) 
1.60+_0.50 4.72+_1.00 
In comparison of pleural fluid characterstics of transudative and 
exudative effusions,it was found that  pleural fluid protein in the transudative 
group was(1.60±0.50) and mean pleural fluid protein in the exudative group 
was (4.72±1) .This had a positive statistical significance in differentiating 
exudates from transudative effusions with a P value=0.0001.This is also 
regarded as one of the criteria in differentiating transudates from exudates as 
per Lights Criteria.  
This table depicts the importance of assessing pleural fluid protein in 
differentaiting exudates from transudates.The mean pleural fluid protein of 
1.60±0.50  was statistically significant for a transudative effusion while a mean 
pleural fluid protein of 4.72+1.00 was statistically significant for an exudative 
effusion with a P =0.0001.This was one of the Lights Criteria for the 
differentaition of transudates from exudates 
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COMPARISION OF THE PLEURAL FLUID CHARACTERSTICS IN 
DIFFERENTIATING EXUDATIVE FROM TRANSUDATIVE 
PLEURAL EFFUSIONS WITH P VALUE  
Table 13 : This table depicts the  pleural fluid characterstics in 
differentiating exudative from transudative pleural effusions 
PLEURAL FLUID 
CHARACTERSTICS 
TRANSUDATIVE 
EFFUSIONS 
EXUDATIVE 
EFFUSIONS 
P VALUE 
PROTEINS(mg/dL) 1.60+_0.50 4.72+_1.00 0.0001 
GLUCOSE(mg/dL) 136.23±55.18 4.72±1.00 0.094 
LDH 103.23±65.76 1566.23±4939.29 0.293 
ADA(u/l) 4.20±2.38 44.71+68.78 0.039 
TOTAL COUNTS 647.69±591.34 3914.89±4013.42 0.0001 
DIFFERENTIAL 
COUNT 
LYMPHOCYTES 
NEUTROPHILS 
 
 
78.15+21.84% 
21.77±21.84% 
 
 
55.30±39.21 
42.17±38.76 
 
 
0.009 
0.019 
The  above table higlights the importance of mainly pleural fluid ADA, and 
pleural fluid total counts in differentiating between exudative and transudative 
effusions.A mean ADA of 44.71±68.78 U/ml  was significant for an exudative 
effusion as compared to a transudative effusion(4.20±2.38) with a 
p=0.039.Similary a mean pleural fluid total counts of (3914.89±4013.42) was 
significant for an exudative effusion as compared to a transudative effusion 
with a P=0.0001.Other values such as pleural fluid LDH,pleural fluid Glucose 
was not found to be statistically significant in differentiating exudates from 
transudative effusions. 
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 COMPARISION OF THE  PLEURAL FLUID CRP IN 
DIFFERENTIATING EXUDATES FROM TRANSUDATES 
 
This  bar diagram draws comparison of pleural fluid crp in 
differentiating exudates from transudates 
 
In differentaiting transudates from exudates a mean pleural fluid CRP of 
1.03±1.20 was significant for a transudative effusion ,while a pleural fluid CRP 
of 5.71±7.33 was significant for an exudative effusion with a positive statistical 
significance with P =0.0001.The result of our study was in accordance with 
other similar studies and pleural fluid CRP proved to be a useful adjunct in 
differentaiting exudative from transudative effusions. 
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Table 14 
PLEURAL 
FLUID 
CHARACTERS 
TRANSUDATIVE EXUDATIVE P  VALUE 
CRP 1.03±1.20 5.71±7.33 0.0001 
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In analysing the  test resulst a pleural fluid CRP of 1.05 had a ROC of 
0.82 with sensitivity of 74.5% and specificity of 76.9% for differentaiting 
netween transudative and exudative effusions 
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COMPARISION OF THE  CLINICAL VARIABLES AMONG THE 
SUBJECTS WITH EXUDATIVE PLEURAL EFFUSION 
Table 15 : This table draws comparison of clinical variables among 
the subjects with exudative pleural effusion 
 
 MALIGNANCY PARAPNEUMONIC TUBERCULAR P VALUE 
AGE(YEARS) 57.60±13.7 51.93±15.51 42.6±21.09 0.063 
GENDER(males) 8(53.3%) 12(80%) 11(73.3%) 0.260 
BMI(kg/m2) 25.26±1.57 25.78±1.39 24.37±1.22 0.03 
SMOKING 5(33.3%) 9(60%) 6(40%) 0.310 
ALCOHOL 0 6(40%) 3(20%) 0.024 
SYMPTOMS 
BREATHLESNESS 
CHEST PAIN 
COUGH 
FEVER 
HEMOPTYSIS 
 
12(80%) 
5(33%) 
12(80%) 
2(13.3%) 
0 
 
9(60%) 
4(26.7%) 
8(53.3%) 
9(60%) 
2(13.3%) 
 
5(67.7%) 
6(40%) 
13(86.7%) 
8(53.3%) 
0 
 
0.734 
0.741 
0.092 
0.02 
0.123 
COMORBID 
CONDITIONS 
 
COPD 
DM 
SHT 
CAD 
RENAL 
 
 
 
3(20%) 
2(13.3%) 
3(20%) 
0 
0 
 
 
 
3(20%) 
6(40%) 
2(13.3%) 
2(13.3%) 
1(6.7%) 
 
 
 
 
 
1(6.7%) 
3(20%) 
0 
0 
0 
 
 
 
0.508 
0.209 
0.207 
0.123 
0.360 
The above table compares all the clinical variables in different exudative 
pleural effusions.On analysing the different clinical variables in different 
exudative pleural effusions,there was found to be no statistically significant 
clinical variable between the three groups .In short our study concluded that 
using only the clinical variables differntaition between the three exudative 
groups were not possible 
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COMPARISION OF THE  AGE AND GENDER BETWEEN  
EXUDATIVE PLEURAL EFFUSION 
Table 16 : This table depicts average age and gender distribution 
between malignant,parapneumonic and transudative effusions 
SOCIO 
DEMOGRAHIC 
VARIABLES 
PARAPNEUMONIC MALIGNANT TUBERCULAR 
AGE(YRS) 51.93+_15.51 57.60+_13.7 42.6+_21.09 
GENDER(MALES) 12 8 11 
FEMALES 3 7 4 
 
No significant difference between the variables wer found on analysis. 
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COMPARISON BETWEEN THE HEMATOLOGICAL 
VARIABLES AMONG THE EXUDATIVE EFFUSIONS 
 
Table 17 : The following table depicts the various hematological 
parametres compared between the various exudative effusions 
HEMATOLOGICAL 
VALUES 
MALIGNANCY PARAPNEUMONIC TUBERCULAR 
P 
VALUE 
HB 12.11±3.06 11.18±1.77 11.43±2.16 0.548 
TLC 10266±4591 16480±5722 13086±20088 0.394 
ESR 48.8±34.56 75.5±32.75 59.67±24.43 0.067 
PLATELETS 311533±126186 271666±113933 339666±142565 0.572 
The above table depicts the basic hematological paramaters assessed 
between the various exudative pleural effusions.Though non of the 
hematological parameters have been proved to be significant in differentaiting 
the exudative effusions.Serum ESR  with a mean value(75.5±32.75) has been 
found to be significant in parapneumonic effusion when compared to tubercular 
and malignant effusion with a statsistical significance of  0.067 .This is in 
accordance to other similar studies which has found a higher ESR in the 
parapneumonic category as compared to malignant and tubercular effusions 
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COMPARISON OF BIOCHEMICAL  VALUES(SERUM 
PROTEINS) AMONGST EXUDATIVE EFFUSIONS 
Table 18 : The below mentioned table signifies that no significant 
difference in serum proteins were noted in the different exudative 
effusions 
BIOCHEMICAL 
VALUES 
MALIGNANT PARAPNEUMONIC TUBERCULAR 
TOTAL 
PROTEINS(mg/dL) 
6.92+_0.46 6.58+_0.50 3.52+_0.27 
ALBUMIN 3.51+_0.59 3.21+_0.43 3.37+_0.42 
GLOBULIN 3.43+_0.33 3.36+_0.64 3.52+_0.27 
In comparing serum proteins amongst the different exudative 
effusions,there was found to be no statistical correlation between serum protein 
and exudative effusions and they had no statistical significance when compared 
to the various exudative effusions. 
This is in accordance to other similar stuides which found no significant 
difference amongst the various exudative efuusions based on serum proteins 
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COMPARING  PLEURAL FLUID CHARACTERSTICS 
AMONGST DIFFERENT EXUDATIVE EFFUSIONS 
In comparing the pleural fluid characterstics amongst various exudative 
effusions it was noted that not all pleural fluid parameters were correlating with 
the nature of the effusion.The parameters with statistical significance were 
pleural fluid differential counts were in a mean lymphocyte 
predominance(74±32.56) and neutrophils(19.20±25.71) were significant for a 
malignant effusion, parapneumonic effusions  had a mean neutrophil 
predominance(85.60±17.79) and a lymphocyte predominance of (14.13±17.81) 
and in tubercular effusiosns  the mean lymphocyte predominance 
was(76.53±31.25) and neutrophil predominance of (23.20±30.71) all of which 
had a P=0.0001 which was statistically significant.This was in accordance with 
other studies which showed similar results.Other pleural fluid parameters that 
were studied include pleural fluid proteins,glucose,LDH,ADA and total 
counts.Off which a pleural fluid ADA of (59.75±115.46) and a mean pleural 
fluid ADA (57±25.48)  had a P=0.274 for parapneumonic and tubercular 
effusions respectively.This is also in accordance with studies which states that 
high ADA(80) were more significant for a  parapenumonic effsuion as 
compared to a tubercular effusions were in ADA(40). 
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 Table-19 : The following table analysis the significance of pleural 
fluid parameters in the exudative effusions . 
PLEURAL FLUID 
CHARACTERSTICS 
MALIGNANCY PARAPENUMONIC TUBERCULAR P 
VALUE 
PROTEIN(MG/DL) 4.76±0.96 4.28±0.98 5.3±0.76 0.013 
LDH 713.07±726.2 3433.2±8561.05 740.8±901.04 0.241 
GLUCOSE 98.66±32.07 113.72±82.93 101.2±79.32 0.815 
ADA 22.66±20.37 59.75±115.46 57±25.48 0.274 
TOTAL COUNTS 1970±2767 6722±4324 3361±3588 0.003 
This table also shows that a mean pleural fluid LDH(3433.2±8561.05) 
was significant for a parapneumonic effusion with a P =0.241.However  the 
pleural fluid LDH values were not significant to distinguish between tubercular 
and malignant effusions.This has been studied in other studies too which 
reflected on the importance of pleural fluid LDH as one of the parameters for 
assessing a parapneumonic effusion. 
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COMPARISON BETWEEN PLEURAL FLUID DIFFERENTIAL 
COUNT AND EXUDATIVE  EFFUSIONS. 
The following table  highlights the importance of pleural fluid 
differential count in differentiating between exudative effusions 
In the first table,neutrophil predominance was assessed with the 
exudative effusions and higher pleural fluid neutrophils were associated with a 
parapneumonic effuion(85%) as compared to malignant and tubercular effusion  
PLEURAL FLUID 
DIFFERENTIAL 
COUNT(cells/mm3) 
MALIGNANT TUBERCULAR PARAPNEUMONIC 
NEUTROPHILS 19.2  25.71 23.2030.71 85.6017.79 
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This below mentioned table depicts the,lymphocyte predominance  
assessd within  the exudative effusions and higher pleural fluid lymphocytes 
were seen in malignant and tubercular effusions as compared to a 
parapneumonic effusion. 
PLEURAL FLUID 
DIFFERENTIAL 
COUNT(cells/mm3) 
MALIGNANT PARAPNEUMONIC TUBERCULAR 
LYMPHOCYTES 7432.56 14.1317.81 76.5331.25 
The above mentioned results are in accordance with the similar results 
obtained from other studies 
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COMPARISON OF PLEURAL FLUID CRP BETWEEN 
EXUDATIVE EFFUSIONS 
On comparing the pleural fluid CRP values amongst the exudative effusions of 
varying etiology,it was obsereved that a mean pleural fluid CRP of (1.68±2.24) 
was observed in malignant effusions,in parapneumonic effusions the mean 
pleural fluid CRP was (12±9.86) and in tubercular effusions the mean pleural 
fluid CRP was observed to be(3.90±3.04) with a statistical significance of 
P=0.006.This was in accordance with other similar results obatined from other 
studies. 
The following  graph  highlights the importance of pleural fluid CRP 
and various exudative effusions 
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On  further analysis of pleural fluid CRP by ROC it was found that for 
parapneumonic effusions,analysis of pleural fluid CRP with ROC=0.88,and 
P=0.0001  had a sensitivity of 80% and specificity of 80% in discriminating 
parapneumonic from malignant and tubercular effusions.   
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Similarly pleural fluid CRP was not obatined for the differentaition of 
tubercular and  malignant effusions were ROC=0.477 and 0.136 respectively 
Similar results wer obtained from other studies which concluded that 
pleural fluid CRP was an useful adjunct with Lights Criteria for initially 
differentaiting exudates from transudative pleural effuisons and further on can 
be used to differentiate between parapneumonic from tubercular and malignant 
in the exudative group which was a similar finding which was noted in our 
study. 
  
  
 
 
 
 
 
Discussion 
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DISCUSSION 
The important findings in our study were as follows 
1. Pleural fluid CRP was an useful adjunct to the Lights Criteria for 
differentiating between transudative and exudative effusions 
2. In case of exudative effusions, pleural fluid CRP was helpful in 
differentiating  parapneumonic effusions from tubercular and malignant 
effusions  
Pleural effusion is primarily characterized by accumulation of fluid between 
the pleural surfaces .Approximately 3 million cases of pleural effusion are 
detected worldwide per annum. Diagnosis of pleural effusion provides a 
challenge to the clinician in routine clinical practice .Initial step in management 
includes differentiation of pleural effusions as exudates and transudates, which 
is done by the Lights criteria, in case of transudates no further management is 
needed, other than treating the underlying pathology(CHF,DCLD,Renal 
disease).In case of an exudative effusion, further diagnostic modalities are 
required to clinch a diagnosis which is time consuming and expensive and this 
goes a long way in the management of the same. 
 The aim of our study was to evaluate the role of pleural fluid CRP as a 
reliable biomarker in separating pleural effusion. We found that ,a pleural fluid 
CRP value of 1.05 had a good sensitivity and specificity(74.5%,76.9% 
respectively) in separating transudative from exudative pleural effusions with a 
69 
 
ROC 0.82.Further on amongst the exudative effusions a pleural fluid CRP 
of(5.25 mg/dL  and above) had 80% sensitivity and 80% specificity in 
differentiating parapneumonic from tubercular and malignant effusions with a 
ROC of 0.888 and a P=0.0001.Thus pleural fluid CRP when used along with 
the Lights Criteria was an useful adjunct in differentiating transudates from 
exudates and to further differentiate parapneumonic from tubercular and 
malignant effusions amongst the exudative group. 
Further on pleural fluid CRP is relatively inexpensive, non invasive, less 
time consuming when compared with the other biomarkers in differentiating 
pleural effusions and has proved to be useful as an ideal biomarker in low 
income settings were the use of other invasive diagnostic modalities for the 
same will be difficult. 
SOCIODEMOGRAPHIC CHARACTERS: 
In our study  60 subjects were recruited off which 39 were males and 21 
were females  with a mean age of 52.8517.77 years. This was comparable to 
another  study by Ahemad et al (25) were in 100 patients were recruited of which 
60 were males and 40 were females with a mean age of 54.5 10.7 years .A 
study by Wafaa et al (24) conducted on 54 patients , in which 36 patients were 
males and 18 were female participants with a mean age of 5510.4 years was 
also comparable to our study.  
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It was found that there was no significant difference between the age 
and gender distribution characteristics in both the studies were the P value=0.9 
was not statistically significant. Our study yielded a P =0.341 on comparing the 
age and gender variables . Gabhale et al(26) in another study on 187 patients 
with pleural effusion highlighted the importance of gender in pleural effusions 
were in males had a higher incidence of malignant and tubercular effusions as 
compared to females(77.6% and 67% respectively as compared to 22.4% and 
33.3% respectively) with P=0.005 which was statistically significant . 
Similary their study highlighted the importance of age in differentiating 
pleural effusions were the mean age of the study population was 44.1216.5 
years as compared to the age group of malignant effusions which was 
higher(59.811.86 years) which was statistically significant (P<0.001), 
attributing the same to malignancy occurring in the fifth – seventh decade of 
life. This was in accordance to our study which had a similar age group of 
patients in the malignant group(57.613.7 years with a P=0.063) .  
Qiaoying et al(27) in a study conducted in 209 patients were in 122 were 
males and 87 were females with a mean age of 56 years found no statistical 
significance between age and gender distribution amongst the study groups. 
On assessing the BMI amongst study participants in our study, it was 
found that the mean BMI amongst the study population was 25.381.54 kg/m2 
which was not statistically significant(p=0.134). Gabhale et al(26) found no 
statistical correlation between BMI and the nature of pleural effusion amongst 
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the study groups were the mean BMI-24.561.82 kg/m2.This was in 
accordance with our study. Yadav et al(16) in study conducted amongst 187 
patients with pleural effusion also found no significant correlation between 
BMI and the study groups. Similary no studies till date have proven the role of 
BMI in assessing patients with pleural effusion and correlating its significance 
in the same. 
Assessing the significance of smoking and alcohol intake in our study it 
was found that, off the 47 exudative effsuions,20 were smokers and in 13 
transudative effusion 4 were smokers which was not statistically significant 
with P =0.443.Similarly alcohol intake was correlated with pleural effusion in 
our study which showed that off the 47 exudative effusions, 9 participants had 
a history of alcohol intake while amongst the 13 patients with transudative 
effusion only 1 patient had a history of alcohol intake .No significant 
correlation was found between alcohol intake and study groups with P=0.327. 
Waffa et al(24) also reported similar findings that there was no positive 
correlation between smoking and alcohol and the study groups. Similarly no 
study has analyzed the relation between these parameters  and pleural effusion. 
Thus concluding that on individual basis smoking and alcohol had no 
significance in differentiating pleural effusions and their presence could not be 
taken as a reliable indicator for the classification of pleural effusion. 
On analyzing the symptomatology and nature of pleural effusion, our 
study found that off the 13 patients with transudative effusion- breathlessness 
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was seen in 9 patients(69.2%),cough in 6 patients(46.2%),chest pain in 4 
patients(30.8%) and fever in 1 patient(7.7%). Similarly in 47 patients with 
exudative pleural effusion,32 patients had breathlessness(68.1%),cough in 35 
patients(74.5%),19 patients had fever(40.4%),chest pain 15 patients(31.9%). 
Correlating the symptomatology with pleural effusion it was found that 
symptomatology had no positive statistical significance to delineate the nature 
of pleural effusion(P=0.957).  
Gabhale et al(26) analyses the symptamatology with nature of pleural 
effusion and found that chest pain as the most common 
symptom(80.74%),followed by cough(77%).However no statistical 
significance was seen with nature of the symptom and pleural effusion, further 
on stated that none of the patients of pleural effusion were with out any chest 
symptom.   
These results were consistent with our study were similar findings were 
noted. Amitabha et al(28) in a study conducted on 110 patients with pleural 
effusion found variation  as compared to our study were cough(40.2%) and 
dyspnea(33%) were less commonly observed, while chest pain(86.8%), 
fever(68.4%) were observed as the next common complaints .However all the 
above mentioned studies concluded that symptomatology was not conclusive 
enough for differentiating pleural effusions. Similarly our study assessed the 
prevalence of co morbidities and nature of pleural effusion. Amongst the 13 
transudative effusions, CAD and diabetes were the most commonly associated 
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co morbid conditions  both having 8 patients in each group(61.5%),followed by 
Hypertension(7,53.8%) and renal involvement in 5 cases(38.5%),were in there 
was a positive correlation between CAD, DM and transudative effusions 
(P=0.0001 and 0.015 respectively).In the exudative effusions off the 47 patients 
,there was no significance between nature of the effusion and the co morbid 
condition.  
This is in contrast to a study by Mansour et al(25) who found no 
statistical significance between nature of co morbid condition and the study 
population. The fact that there was a positive relation between co morbid 
conditions and transudative effusions highlight the importance of the same in 
differentiating transudative from exudative effusions as we have done in our 
study. Similarly there was no positive correlation between exudative effusions 
and the comorbid conditions as highlighted by our study which further 
emphasize on the fact that predominantly co morbid conditions were seen in 
transudative effusions and thereby increasing the need to effectively treat the 
underlying pathology in a transudative effusion. 
On analyzing the hematological variables in our study, it was found that 
for the transudative group  the mean  values for hemoglobin (9.641,69), TLC 
(97462641), platelets (23562087602) and ESR (41.5415.88) had no 
statistical significance in differentiating pleural effusion. Similarly in the 
exudative groupt the mean Hb (11.372.51), TLC (1328912070), platelets 
(313530128618) and ESR (60.2832.14).There was no positive correlation 
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between the study groups on determining the hematological variables as was 
evidenced by our study(P=0.30). 
Similar findings were noted by Qiayoying et al(27) in study conducted in 
209 patients. Thus it was proved that analysis of hematological parameters had 
no significant impact on the nature of pleural effusion. Other biochemical 
parameters total protein ,serum albumin and serum globulin were analyzed in 
our study which showed no statistical significance between these biochemical 
parameters and pleural effusion with a p=0.199.Similary no studies have 
individually analyzed the importance of serum proteins and classification of 
pleural effusion and thus it can be concluded that the analysis of serum proteins 
had no significance in the differentiaon of pleural effusion as stated in our 
study. 
COMPARISON OF PLEURAL FLUID PARAMETERS BETWEEN 
THE STUDY GROUPS : 
In our study we analyzed the importance of  each pleural fluid parameter 
and its importance in individually differentiating a pleural effusion. Amongst 
the 13 patients with transudative pleural effusion the mean pleural fluid protein 
was(1.60.50) which when compared with the exudative group had a statistical 
significance of P=0.0001 were the mean pleural fluid protein 
was(4.72+_1).Similarly pleural fluid LDH levels were significantly elevated in 
the exudative group (15664939) as compared to the transudative 
group(103.2365.76) with a P =0.293. 
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Pleural fluid total count was also noted to be elevated in the exudative 
group were the mean was(3914.894013.42) as compared to the transudative 
group( 647591.34) with a P=0.0001.These values obtained by our study is in 
direct consensus with Lights Criteria in differentiating transudative effusions 
from exudative effusions were importance was given to the pleural fluid LDH 
and pleural fluid protein level for the classification of pleural effusion. Similar 
findings were noted in a study conducted by Hassan et al(10) which concluded 
that assessing the pleural fluid LDH and pleural fluid protein levels had a 
positive statistical correlation in differentiating exudative from transudative 
effusions(p=0.000). 
Other studies also quoted the significance of assessing pleural fluid 
LDH, pleural fluid proteins and pleural fluid total count in differentiating 
transudative from exudative effusions and found positive correlation between 
both. Other pleural fluid parameters like pleural fluid glucose, and pleural fluid 
differential counts were assessed and their correlation with the classification of 
pleural fluid transudates or pleural fluid exudates were considered insignificant 
(P=0.094 and 0.019 respectively).Our study was in accordance with other 
studies which obtained similar in significant results in comparing pleural fluid 
glucose and pleural fluid differential count in the differentiating exudates from 
transudative pleural effusion. 
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COMPARISON OF PLEURAL FLUID CRP IN 
DIFFERENTIATING PLEURAL FLUID EXUDATES FROM 
TRANSUDATES: 
Our study analyzed 60 subjects with pleural effusion of which based on 
clinico radiological and pleural fluid biochemical properties they were 
separated into transudates and exudative pleural effusion. Amongst the 60 
pleural effusions,13 were transudates and 47 were exudates. On analysis of 
pleural fluid CRP between the two groups, it was found that a pleural fluid 
CRP of 1.05 mg/dL had 75% sensitivity and 77% specificity in differentiating 
exudative from transudative effusions with a ROC=0.825 which was 
statistically significant and thus proved that pleural fluid CRP can be used as an 
adjunct with the Lights criteria in classification of transudative and exudative 
pleural effusion. Our results were similar to other studies which showed similar 
findings.  
Waffa et al(24) in a study conducted on 54 patients showed that the mean 
pleural fluid CRP in a transudative effusion(1.113+_0.574 mg/dL) which was 
statistically significant with P=0.002. Mansour et al(25) in a similar study 
conducted on 110 patients found similar but slightly higher values for pleural 
fluid CRP in differentiating pleural fluid transudates from exudates were  a 
mean pleural fluid CRP for a transudative effusion was(5.70.9) and similarly 
for an exudative effusion was(16.17.2) with a P=0.0001. 
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Hoda et al(17) also published similar reports in a study stating higher 
pleural fluid CRP in exudative effusions as compared to transudative effusion 
with a P value <0.003.Alexandris et al(12) in a study conducted on 84 patients 
with pleural effusion, found similar results as to our study ,were in a pleural 
fluid CRP of 1mg/dL had a sensitivity and specificity of 74% in differentiating 
exudative from transudative pleural effuions with a P value<0.001 and 
concluded that pleural fluid CRP as a good biomarker in differentiating 
transudative from an exudative pleural effusion.In another similar study by 
Castano et al(23), were 72 patients were recruited for the study, a  mean pleural 
fluid CRP of 1mg/dL had a positive correlation with p<0.001 in differentiating 
exudative from transudative pleural effusion. 
Rezaeetalab in a study too proved that pleural fluid CRP were higher in 
exudates as compared to transudates with a p<0.05.Thus our study is in 
accordance with all the above mentioned studies in concluding that lower level 
of pleural fluid CRP was found in transudative  effusions as compared to 
exudative effusions with a strong statistical correlation .This proves that pleural 
fluid CRP can be a useful adjunct with the Lights criteria in differentiating 
exudates from transudates which is the initial step in the management of pleural 
effusion. 
 
 
78 
 
COMPARISON OF SOCIODEMOGRAPHIC VARIABLES IN 
EXUDATIVE PLEURAL EFFUSION. 
Our study correlated  the socio demograhic variables in the classification 
of exudative effusions. With respect to age there was a significant correlation 
between the exudative groups. The mean age for the malignant group 
was(5713.7),for parapneumonic group(51.9315.51) and tubercular group 
was (42.621.09) were the P=0.063. 
Gabhale et al(26) too found higher incidence of age in the malignant 
group with a mean age(59.811.86 years) as compared to a mean age of 
(44.1216.5 years) in other effusions. This was attributed to the higher 
incidence of malignancy seen in the fifth-seventh decade of life. In relation to 
BMI and the classification of an exudative effusion there was no significant 
relation between the same were the mean BMI for malignant(25.261.57),for 
parapneumonic group was(25.781.39) and for tubercular group 
was(24.371.22) with a P value of 0.03 which was insignificant. Similar results 
were obtained by El shimy et al(24) and Mansour et al(25) in their respective 
studies. In our study we found that on analysing gender with exudative pleural 
effusions, male predominance was noted for each of the exudative effusion. Off 
the 15 malignant effusion,8 were males(53.3%)in the parapneumonic group 12 
were males(80%) and 11 were males in the tubercular effusion 
category(73.3%) with a p=0.260. 
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This was directly correlated to the smoking incidence which was 
observed amongst the male gender. On similar assessment of the 8 malignant 
effusion which were males 5 were smokers(62.5%) there by showing a positive 
correlation between smoking and malignancy. 
Gabhale et al(26) in a similar study showed the higher incidence of 
malignant effusion in the male population as compared to females(78% and 
22% respectively) and attributed this to the smoking and alcohol habits in the 
male population. Concluded that risk of malignancy was three times increased 
in the male population. They found a similar increase in the number of males in 
the parapneumonic category with male to female ratio being 3:1. 
This was in accordance to similar findings noted in our study were off 
the 15 parapneumonic effusions,12 were males(80%).In assessing the 
symptomatology amongst exudative effusions, our study noted that 
breathlessness was a common finding in twelve of the 15 cases of malignant 
effusion, followed by cough which was seen  in 12 cases of the 15 malignant 
effusion  with a P=0.092.Similar findings were noted by Gabhale et al(26) in a 
study which concluded that the most common symptom in a malignant effusion 
was chest pain(80.74%) followed by cough(77%) which is in accordance with 
our study. 
Also other studies have quoted variable frequency of chest symptoms 
amongst exudative effusions to which our study was not in accordance with. 
However in our study, we found that there was no significant difference when 
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other symptamatology was assessed between other exudative effusions with an 
insignificant correlation with P=0.734. 
Other sociodemographic variables assessed in our study included the 
distribution of co morbid conditions and nature of exudative effusions. The 
comorbdities analyzed were COPD,DM,HTN and CAD all of which had no 
predominance amongst the exudative effusions with a P=0.508.Similar studies 
have analysed the prevalence of co morbid conditions and exudative effusion 
and have found no statistical significance for the same.There by concluding 
that comorbidities were not a criteria for analysing the  exudative 
effusions,unlike the transudative effusions were comorbid conditions play a 
role as proved by our study previously. 
ANALYSIS OF HEMATOLOGICAL VARIABLES IN 
EXUDATIVE EFFUSION : 
On analyzing the hematological variables with respect to exudative 
effusion,our study concluded that apart from ESR there was no significant 
correlation between other hematological variables and exudative effusions. 
ESR when analysed was found to be significantly higher in the parapneumonic 
category(75.532.75) as compared to malignant or tubercular 
effusions(48.834.56 and 59.6724.43 respectively). 
Similarly TLC was analyzed in our group and only a marginal 
difference was noted amongst the exudative effusions which was in accordance 
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with  Gabhale et al (26) were TLC was found to be elevated in parapneumonic 
group followed by tubercular and malignant were the p=0.70 which was 
insignificant. This was attributed to the inflammatory process on going in a 
parapneumonic effusion. On reviewing other hematological variables  ,their 
correlation with the exudative effusion was considered insignificant .Other 
variables analyzed in our study were platelets and Hb which were insignificant 
with p=0.548 and 0.572 respectively. Similarly assessment of serum proteins 
were also insignificant in the differentiation of exudative effusions as 
demonstrated by our study. Similar findings were also observed in other 
studies. 
ANALYSIS  OF PLEURAL FLUID PARAMETERS AMONG 
SUBJECTS WITH EXUDATIVE EFFUSION 
The various pleural fluid parameters analyzed in our study were pleural 
fluid LDH,ADA, protein, glucose ,total and differnential counts. Our study 
concluded that on analysing certain parameters like pleural fluid LDH, ADA, 
total and differential counts there was a significant difference between the  
exudative effusions of different etiology and was also proved in studies quoting 
similar results. In our study, the mean pleural fluid LDH in parapneumonic, 
malignant, tubercular effusions were(3433.28561.05), (713726.20), 
(740.8901.04) respectively with a p=0.24. 
Though parapneumonic effusions had a larger range of pleural fluid 
LDH, no similar differences amongst tubercular and malignant effusions were 
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noted. Similar studies have proved that a higher range of pleural fluid LDH was 
noted in parapneumonic effusion as compared to tubercular and malignant 
effusion was noted in our study 
Another pleural fluid variable assessed was the pleural fluid ADA 
amongst exudative effsuions.It was found that pleural fluid ADA was lowest in 
the malignant group (22.6620.37) as compared to parapneumonic and 
tubercular effusions(59.75115.46) and (5725.48) respectively with p=0.27.It 
was seen that  there was no difference in pleural fluid ADA when compared 
between the parapneumonic and tubercular group.  
Nusrath et al(22) in a study concluded the effectiveness of pleural fluid 
ADA and stated that a ADA(40) had a good sensitivity and specificity in 
differentiating tubercular effusions from other exudative effusions with a 
P<0.001.This was in accordance to our study which had near similar results on 
comparing pleural fluid ADA.  
Motoki S(35) et al gave a similar report regarding pleural fluid ADA 
werein an ADA of <50IU/L had a good sensitivity and specificity in 
differentiating tubercular from malignant and parapneumonic effusions.  
Wipa et al(29) reported that when a pleura fluid ADA with cut off 48U/L 
was estimated ,it had a sensitivity of 80% and a specificty of 80.5% 
respectively. Similarly Burgess et al(30) showed 90% sensitivity and 89% 
specificity for an ADA of 50 U/L in differentiating tubercular from malignant 
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and parapneumonic effusions. In a report by E,Garcia et al(31) which showed 
contrasting views on pleural fluid ADA from the above mentioned studies, 
concluded that a higher pleural fluid ADA(73U/L) was associated with 
mesotheliomas and quoted as one third of the patients with mesotheliomas to 
have a higher pleural fluid ADA value.Similar observation was also noted by 
Verma et al(32) were the ADA for malignant effusion was(87.618.5 U/L) 
which was contrasting to our study. Verma et al(32), Arun G et al(39) also stated 
that high pleural fluid ADA were also noted in patients with rheumatoid 
arthritis,fungal infections and in cases of empyma apart from malignant 
effusions. Rafael LL(40) highlighted the over implication of pleural fluid ADA 
in the diagnosis of tubercular effusion. 
On analysis of pleural fluid total counts in our study it was found that 
parapneumonic effusions had a higher pleural fluid counts as compared to 
tubercular and malignant effusions (67224324), (33613588) and 
(19702767) respectively with a statistical significance P=0.03.In turn 
attributing the increase in total counts to the ongoing inflammatory condition 
associated with a parapneumonic effusion .Huang et al(27) quoted similar 
findings in their study were in a higher pleural fluid leukocyte levels were seen 
associated with parapneumonic effusions as compared to tubercular and 
malignant effusions.  
Gabhale et al(26) also found similar findings in their study, and 
concluded that pleural fluid leukocyte count was higher in parapneumonic 
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effusions as compared to tubercular and malignant effusion, though the 
difference in the total counts were insignificant=0.70. Further analysis of 
differential counts in the exudative group in our study found significant 
diffrence in differential count between paraneumonic as compared to tubercular 
and malignant effusions.The mean pleural fluid differential count  found a 
neutrophil predominance in parapneumonic effusion as expected(85.6017.79 ) 
and a mean lymphocyte count(14.1317.81) as compared to a lymphocyte 
predominant tubercular effusion(7631.25) with a P value=0.0001 which was 
statistically significant. However no significant differential count 
predominance was seen in the malignant group in our study.  
The neutrophil predominance was seen in parapneumonic effusions as 
they were acute onset and a neutrophil predominant cell population was 
expected in the initial course of an acute inflammation. As the on going 
inflammation continues further, the neutrophil predominance gives way to a 
lymphocytic predominant effusion which was evident as proved by a 
lymphocyte predominant effusion as seen in our tubercular effusion and 
malignant effusion. This was in accordance to San jose et al(15) who highlighted 
the importance of cell counts in differential diagnosis of pleural effusion and 
stated that  a total neutrophil count had sensitivity of 64.3%  and a specificity 
of 93.4% in the diagnosis of a parapneumonic effusion with a ROC=0.836 
which was statistically significant .In another study by Perlat et al(11) ,the 
presence of a neutrophilic cell predominance ,leucocytosis were significant of a 
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pleural effusion of an infectious origin(parapneumonic effusion) and went to 
state that a lymphocytic predominant effusion were seen in a sub acute to 
chronic condition there by explaining the lymphocytic predominant tubercular 
and malignant effusion as in our study.  
A similar study by Trajman A et al(33) in diagnosis of a tubercular 
effusion quoted as saying that a pleural fluid lymphocyte level of(>90%) were 
significant for tuberculosis or lymphoma while a neutrophilic level of more 
than 80% was significant of a paraneumonic effusion which was in accordance 
with our study.  
Porcel at al(2) too justified a similar finding stating that a lymphocytic 
predominant effusion was more in favor of tubercular or malignant effusion 
while a neutrophilic predominant effusion was significant of a parapneumonic 
effusion which is again in accordance to our study results . 
Hassan et al(10) too yielded similar results stating the importance of cell 
group predominance in identifying the nature of an exudative effusion. The 
other pleural fluid parameter which was analyzed in our study was pleural fluid 
glucose which was found to be increased in parapneumonic 
effusions(11382.93) and was insignificant variable in the diffrerential 
diagnosis of an exudative effusion with a p=0.815 as per our study. This was 
not in accordance to other studies which proved that pleural fluid glucose was 
the lowest in a parapneumonic effusion(465.3 mg/dL) and highest in a 
malignant effusion(85.642) and a glucose of <60 mg/dL was seen in 
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complicated parapneumonic effusion with a statistical significance of 0.006.No 
other study has highlighted the importance of pleural fluid glucose as a 
parameter in differentiating between exudative pleural effusions. 
COMPARISON OF PLEURAL FLUID CRP WITH EXUDATIVE 
EFFUSIONS : 
CRP is an acute phase reactant which is generated by the hepatocytes in 
response to the inflammatory process .In case of an inflammatory effusion ,due 
to the increased permeability of the pleural membranes, CRP diffuses through 
the same and is found in the pleural fluid there by signifying an increased 
pleural fluid CRP which is associated with an exudative effusion especially of 
the parapneumonic variety. Further studies have correlated the importance of 
pleural fluid CRP in a malignant effusion stating that since malignancy is an 
inflammatory condition, this explains the increase in pleural fluid CRP in a 
malignant effusion. Further on the prognostic value of pleural fluid CRP was 
evaluated by Scott et al(21) who proved that higher CRP levels indicated a poor 
overall survival rate, attributing to the fact that increased CRP levels were 
corresponding to cachexia and poor mineral bone density there by contributing 
to the poor overall survival rate. Similar studies by Garcia et al(37) and Okamura 
et al(38),too evaluated clinical applications of CRP in differential diagnosis of 
exudative pleural effusion. 
In our study we analyzed the significance of pleural fluid CRP in the 
different exudative effsuions and found that parapneumonic effusions had a 
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higher pleural fluid CRP(12+_9.86),followed by tubercular effusion(3.903.04) 
and malignant effusion(1.682.24) with a p=0.006 which was statistically 
significant. Further on our study showed that on using a pleural fluid CRP of 
5.25 and above there was 80% sensitivity and specificity in discriminating 
parapneumonic from the malignant and tubercular effusions with ROC=0.888 
which was highly significant .This was in accordance to the above mentioned 
path physiology of increased pleural fluid CRP which was associated with a 
parapneumonic effusion. 
San jose et al(15) in a study correlated the pleural fluid CRP in 
parapneumonic effusions and stated that higher pleural fluid CRP was observed 
in the parapneumonic group as compared to the other groups with a p<0.001-
0.004) which was statistically significant. Similar study by Perlat et al(11) too 
found similar results in using pleural fluid CRP as a differentiating factor and 
found that a mean level of 5733.7 mg/L had a sensitivity of 94.7% in 
differentiating a parapneumonic from other exudative effusions and concluded 
that pleural fluid CRP values were highest for a parapneumonic effusion, 
followed by tubercular and malignant effusion. Gabhale et al (26)too found high 
values of pleural fluid CRP(13422.9 mg/L) in parapneumonic group as 
compared to the lowest levels seen in the malignant group with mean 
of(26.818.7 mg/L).  
This difference was found to be statistically significant with a P <0.001 
and in the tubercular group the mean pleural fluid CRP was (66.7510.77 mg/l) 
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which was also in accordance to our study .In ROC analysis for analyzing the 
significance of pleural fluid CRP, they said that it gave the largest area under 
ROC curve(1.00) for differentiating parapneumonic effusion from non 
parapneumonic effusion. They also stated that the slightly higher level in 
pleural fluid CRP in a malignant effusion was due to an infectious component 
super imposed on a malignant effusion. Further on the study concluded that for 
an accurate clinical diagnosis of a parapneumonic effusion, a pleural fluid 
neutrophil predominance, and a high pleural fluid CRP had a ROC=0.85 and 
0.82 respectively which was a similar finding which was seen in out study.  
El Shimy et al (24) too proved that a pleural fluid CRP level was lower in 
a malignant effusion(2.491.69 mg/dL) as compared to a parapneumonic 
effusion(6.85+_1.658 mg/dL) and tubercular effusions had a pleural fluid 
CRP(6.9923.72 mg/dL) with a  p=0.003 and 0.002 respectively. This was 
different to our study as a higher mean pleural fluid CRP was obtained in the 
tubercular group when compared to the same in our group. Also the study 
compared pleural fluid CRP in patients of malignant effusion with transudative 
effusion with a p=0.159 which was not correlated in oue study . 
Mansour et al(25) too found a higher value of pleural fluid CRP in the 
parapneumonic group as compared to the other exudative group with a 
statistical significance of p<0.001. Similarly  Yilmaz et al in(34) 97 patients 
analyzed pleural fluid CRP and quoted that it was significantly higher in the 
parapneumonic group as compared to tubercular and the neoplastic group with 
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a p<0.002.Castano et al(23) too correlated the pleural fluid CRP in 72 patients 
with pleural effusion and quoted that a pleural fluid CRP(>10mg/L) had a 
sensitivity of 82% and specificity of 87.5% in the diganosis of parapneumonic 
effusions from other effusions.  
Hoda et al(17) also concluded that pleural fluid CRP was higher in the 
parapneumonic group as compared to the other exudative group, however a 
contradiction to the fact that a higher pleural fluid CRP level was observed in 
the tubercular group as compared to the parapneumonic group as was found in 
our study .Other studies also reported that the highest sensitivity and specificity 
in differentiating  exudates from transudates was a pleural fluid CRP>30 
mg/dL which had a sensitivity of 93.7% and a specificity of 76.5%. 
From comparing our study to the other above mentioned studies it was 
found that  a higher pleural fluid CRP was a useful parameter along with the 
clinical and radiological features in discriminating a parapneumonic effusion 
from other exudative effusions. A mild increase in the mean pleural fluid CRP 
as observed in some studies have been attributed to a super imposed 
inflammatory component in those cases 
Thus it is justified in concluding that pleural fluid CRP is a useful 
adjunct in the discrimination of trasnsudates from exudates along with the 
Lights Criteria and further on a high pleural fluid CRP had a diagnostic 
reliability in differentiating parapneumonic effusion from neoplastic and 
tubercular effusion. 
 
 
 
 
 
 
 
Summary 
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SUMMARY 
Sixty patients with pleural effusion diagnosed by clinico radiological criteria 
were recruited in our study. We evaluated the socio demographic and 
hematological variables  in transudative and exudative effusion.We compared 
the pleural fluid parameters like LDH,ADA,Glucose,Protein and Total counts 
with pleural fluid CRP values to evaluate the role of pleural fluid CRP 
differentiating pleural effuions. The study participants were divded into 
transudates and exudates and further in exudates the patients were divded into 
malignant,parapneumonic and tubercular effusions. Sociodemographic 
variables and hematological variables like total counts,platelets,Hb and ESR 
had no significant correlation between the study groups.We found that a pleural 
fluid CRP of 1.05 mg/dL had a good sensitivity and specificity in 
differentiating transudative effusions from exudative effusions. Further on 
amongst the exudative effusions,a pleural fluid CRP of 5.25 mg/dL and above 
had a good sensitivity and specificity in differentiating parapneumonic from 
tubercular and malignant effusions. 
 
 
 
 
 
 
 
 
 
 
 
 
Limitations  
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LIMITATIONS 
1. Sixty samples were only included in our study due to time constraints 
2. Though pleural fluid CRP proved a good indicator in differentaiting 
exudates from transudates and further in differentiating parapneumonic 
from other exudative  effsuions, it was not a reliable indicator in 
differentiating malignant from tubercular effusions 
3. Pleural fluid glucose was not found to be a reliable indicator in 
differentiating parapneumonic from tubercular and malignant effusions, 
contradictory to other studies 
4. Apart from pleural fluid CRP,an additional biomarker needed to be 
analyzed to differentiate pleural effusions as no single biomarker has 
proven to be significant in differentiating pleural effusions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion 
 
92 
 
 
CONCLUSION 
Our study showed that a pleural fluid CRP of 1.05mg/dL helped in 
differentiating transudates from exudative pleural effuions.In the exudative 
group a pleural fluid CRP of 5.25 mg/dL and above had a diagnostic 
significance in differentiating parapneumonic effusions from tubercular and 
malignant effusions. 
Thereby CRP can be used as a novel biomarker to differentiate 
transudative from exudative effusions. It also has specificity in differentiating 
parapneumonic effusions from other exudative effusions. 
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Annexures 
 
 
ABBREVIATIONS 
COPD :  Chronic Obstructive Pulmonary Disease 
DM : Diabetes Mellitus 
SHT : Systemic Hypertension 
CAD : Coronary Artery Disease 
MPE : Malignant Pleural Effusion 
TPE : Transudative Pleural Effusion 
CPPE : Complicated ParaPneumonic nEffusion 
PPE : Parapneumonic Effusion 
LDH : Lactate Dehydrogenase 
MR pro ANP : Mid Regional Atrial Natriuretic Peptide 
AAG : Alpha 1 Acid Glycoprotein 
AMG : Alpha 2 MacroGlobulin 
LBP : Lipo polysacchride Binding Protein 
TNF : Tumor Necrosis Factor 
VEGF : Vascular Endothelial Growth Factor 
BNP : Brain Natriuretic Peptide 
NT-proBNP : N Terminal Brian Natriuretic Peptide 
 
 
STREM-1 : Soluble Triggering Receptor Expressed on Myeloid cells-1 
  IL-6-Interleukin-6 
AFB : Acid Fast Bacilli 
CYFRA : Cytokeratin Fragment 
CEA : Carcinoma Embryonic Antigen 
TTF1 : Thyroid Transcription Factor 1 
CA : Carcinoma Antigen 
ADA : Adenosine De Aminase 
CRP : C-Reactive Protein 
ls CRP : Low senstivity CRP 
hs CRP : High sensitivity CRP 
 
  
 
 
PSG Institute of Medical Science and Research, Coimbatore 
Institutional Human Ethics Committee 
INFORMED CONSENT FORMAT FOR RESEARCH PROJECTS 
 
(strike off items that are not applicable) 
 
I (write name of the investigator(s) here), Dr.Arun.R.Thomas is carrying out a study on the topic: “A 
HOSPITAL BASED STUDY ON PLEURAL FLUID CRP AS A BIOMARKER IN PLEURAL EFFUSION”. 
 
as part of  our research project being carried out under the aegis of the Department of: Respiratory 
Medicine    
 
(Applicable to students only): our research guide is: Dr.K.Anupama Murthy 
 
The justification for this study is: My study aims at justifying the use of pleural fluid biomarker                       
(CRP) in early differential diagnosis of exudative pleural effusion. 
 
 
 
The objectives of this study are:  
 
1. Primary Objective: To evaluate CRP as a biomarker in differentiating exudative pleural effusion.  
2. Secondary Objective: To assess the diagnostic value of pleural fluid CRP with routine pleural fluid 
parameters in exudative pleural effusions of different etiology. 
 
Sample size: _60_.  
 
Study volunteers / participants are (specify population group & age group): Males & Females, 18 yrs & 
Above 
 
Location:  PSG IMSR. 
 
We request you to kindly cooperate with us in this study. We propose collect background information and 
other relevant details related to this study. We will be carrying out:  
 
Initial interview (specify approximate duration):____5______ minutes.  
 
Data collected will be stored for a period of Five years. We will use the data as part of another study. 
 
Health education sessions: Number of sessions: ___-_ __. Approximate duration of each session: - 
 
Clinical examination (Specify details and purpose):  
Respiratory System  : To detect diminished breath sounds, 
Chest X-Ray PA View  : To detect pleural fluid  
Diagnostic thoracocentesis  : To aspirate pleural fluid for diagnosis 
 
Blood sample collection: Specify quantity of blood being drawn: ______ 5 _____ml.  
 
No. of times it will be collected: ____NA____.  
 
Whether blood sample collection is part of routine procedure or for research (study) purpose:   
 
 
 
 
1. Routine procedure √    2. Research purpose  
 
Specify purpose, discomfort likely to be felt and side effects, if any: Mild discomfort at the time of 
diagnostic aspiration _ 
 
Whether blood sample collected will be stored after study period: Yes / No, it will be destroyed   √  
 
Whether blood sample collected will be sold: Yes / No √  
 
Whether blood sample collected will be shared with persons from another institution: Yes / No √  
 
Medication given, if any, duration, side effects, purpose, benefits: NIL 
 
Whether medication given is part of routine procedure: Yes / No (If not, state reasons for giving this 
medication) 
 
Whether alternatives are available for medication given: Yes / No (If not, state reasons for giving this 
particular medication) 
 
Final interview (specify approximate duration):_____NA____ mts. If photograph is taken, purpose:  
 
1. Benefits from this study: Helps in early differential diagnosis of pleural fluid effusions. 
2. Risks involved by participating in this study: Minimal Risk during Diagnostic thoracocentesis 
How the results will be used:  
 
If you are uncomfortable in answering any of our questions during the course of the interview / biological 
sample collection, you have the right to withdraw from the interview / study at anytime. You have the 
freedom to withdraw from the study at any point of time. Kindly be assured that your refusal to participate or 
withdrawal at any stage, if you so decide, will not result in any form of compromise or discrimination in the 
services offered nor would it attract any penalty. You will continue to have access to the regular services 
offered to a patient. You will NOT be paid any remuneration for the time you spend with us for this interview 
/ study. The information provided by you will be kept in strict confidence. Under no circumstances shall we 
reveal the identity of the respondent or their families to anyone. The information that we collect shall be 
used for approved research purposes only. You will be informed about any significant new findings - 
including adverse events, if any, – whether directly related to you or to other participants of this study, 
developed during the course of this research which may relate to your willingness to continue participation. 
 
Consent: The above information regarding the study, has been read by me/ read to me, and has been 
explained to me by the investigator/s. Having understood the same, I hereby give my consent to them to 
interview me. I am affixing my signature / left thumb impression to indicate my consent and willingness to 
participate in this study (i.e., willingly abide by the project requirements).  
 
Signature / Left thumb impression of the Study Volunteer / Legal Representative:  
 
 
Signature of the Interviewer with date:        Witness: 
 
Contact number of PI: 9677398350 
 
Contact number of Ethics Committee Office:  0422 2570170 Extn: 5818 
 
 
 
 
 
 
  
 
 
   Thesis Project 
 
Title:  HOSPITAL BASED STUDY ON THE ROLE OF CRP AS A BIOMARKER IN PLEURAL EFFUSION 
Department of Respiratory medicine 
PSG IMSR 
 
Case Record Form 
 
Name: ………………………………………. Informant: …………………………............ 
 
Age / sex: …………………………………… CRC. No : …………………………………. 
 
Father’s / Husband’s name: …………………………………………………………………………... 
 
Address: ……………………………………... Height: …………. Weight: …………….... 
 
………………………………………………... BMI: ……………………………………… 
 
………………………………………………...  PSG OP No: ________________________ 
 
   
 
Marital status:       Married            Unmarried             Widow/Widower           
 
No. of family members: …………………… Adults ………. Children ……… (< 12 years) 
 
Dwelling {lived for most part (>70%) of the subject’s life}   Urban  /  Rural 
 
 
Education :        Illiterate   Read & write 
    Primary school  High school 
Higher secondary  Graduate 
Postgraduate   Professional / Fellow / Doctorate  
 
Occupation :     employed            unemployed         retired  housewife 
 
Present : …………………………………………………  Duration : ………………… 
Past : (1) …………………………………………  Duration : ………………… 
 (2)  ………………………………………...  Duration : ………………… 
 
 
Total monthly family income: ……………………… 
 
What is your contribution to total monthly family income? …………………… % 
 
Socioeconomic status(Modified prasad’s classification):   
 
Personal History : 
 
Diet:   vegetarian  /  mixed 
  If mixed diet how frequently you take animal food? 
  Daily  /  weekly  /  fortnightly  /  monthly  /  occasional 
 
Smoking: Yes  /  No  ( presence of regular smoking for at least one year and / or smoked at  
   least 100 cigarettes / beedies / others in his / her lifetime)  
 
If yes, beedi/ cigarette/ hukka /others 
 
 
   No of beedies / cigarettes per day …………………………. 
   Age at started ………………………………………………… 
   If ex-smoker, when stopped ………………………………… 
  
 
Alcohol :   Yes  /  No   
 
   If yes,    Quantity ……………………ml 
     Frequency …………………… 
   If stopped when ………………………….. 
 
  
 
Other informations :  Drugs / narcotics abuse  
 Tobacco / pan chewing 
 Sexual promiscuity 
 
 
Disease specific details: PLEURAL EFFUSION 
 
Duration of illness: 
 
Treatment details(at the time of enrollment): 
 
Past history / Co-existing illness: 
 
 Allergic rhinitis……………………………………………………………………………………………... 
 GERD / Acid peptic disease………………………………………………………………………………… 
 Hypertension………………………………………………………………………………………………... 
 Diabetes mellitus……………………………………………………………………………………………. 
 
 
 Hypo/hyperthyroidism……………………………………………………………………………………… 
 Other endocrine disorders…………………………………………………………………………………... 
 Lung diseases other than COPD……………………………………………………………………………. 
 Heart diseases……………………………………………………………………………………………….. 
 Cerebro vascular diseases…………………………………………………………………………………... 
 Kidney diseases……………………………………………………………………………………………... 
 Obstetric history / Gynecological illnesses…………………………………………………………........... 
 Surgical illnesses .…………………………………………………………………………. 
 Congenital anomalies……………………………………………………………………………………….. 
 Others……………………………………………………………………………………………………….. 
 
 
Family History:   (mention relationship where relevant) 
 
 Atopic diseases……………………………………………………………………………………………... 
 Hypertension………………………………………………………………………………………………... 
 Diabetes mellitus……………………………………………………………………………………………. 
 Hypo/hyperthyroidism……………………………………………………………………………………… 
 Other endocrine disorders…………………………………………………………………………………... 
 Lung diseases ………………………………………………………………………………………………. 
 Heart diseases……………………………………………………………………………………………….. 
 Kidney diseases……………………………………………………………………………………………... 
 Obstetric history / Gynaecological illnesses…………………………………………………………........... 
 Surgical illnesses……………………………………………………………………………………………. 
 Congenital anomalies……………………………………………………………………………………….. 
 Others……………………………………………………………………………………………………….. 
 
 
Physical examination 
 
1. Vitals:                             
 
  Pulse rate: ……………………..               Respiratory rate: ……………………. 
                                           
                                           B.P.: ………………………….                 Temperature: ……………………….. 
 
                                           O2 saturation: ………………... 
 
 
 
 
2. General examination: 
  
     Built              Pallor                cyanosis                clubbing                JVP                 edema             Lymph nodes 
 
  
3. Respiratory system:    
 
4. Cardiovascular System: 
  
5. Others 
 
 
X-ray chest PA view: 
 
 
ECG: 
 
Baseline Blood Investigations: 
 
CBC, Serum LDH, Serum Protein 
 
 
 
Pleural Fluid Parameters, LDH, ADA, Protein, Glucose, Cell Count, Cytology, CRP 
 
 
Diagnostic Thoracocentesis at time of Recruitment 
 
 
 
 
Sl.No Name Age Gender BMI FI Diet Smoking Pack Years Status Alcohol Quantity Status Dyspnea Chestpain Cough Fever Pl.Effusion Hemoptysis COPD DM HTN CAD Renal P/A TLC Platelets Hb ESR pl.LDH ADA Glucose Protein Cytology TC Lymphocytes Neutrophils CRP T.Proteins Alb Glb S.LDH Diagnosis
1 Mrs.Ruckmani 56 0 23.3 8000 0 0 0 0 0 0 0 2 0 0 0 0 0 0 1 0 0 0 1 11,300 3,75,000 9.6 40 127 11 103 3.7 0 980 98 2 0.5 6.2 3.4 2.8 0
2 Mr.Chandran 58 1 26.6 10,000 1 1 30 2 0 0 0 3 1 1 0 1 0 1 1 0 0 0 0 9,900 2,56,000 17.3 23 454 9.7 103 4.2 2 380 99 1 0.8 7.8 4.8 3 0
3 Mrs.Sangeetha 28 0 24.2 9000 1 0 0 0 0 0 0 2 0 0 0 2 0 0 0 1 0 1 0 11,000 1,53,000 8.5 60 73 1.4 118 1.2 0 80 93 7 0.1 5.9 3.3 2.6 3
4 Mr.Vikash 28 1 25.6 10,000 1 0 0 0 0 0 0 1 1 1 1 0 0 0 0 0 0 0 0 18,700 2,67,000 12.2 106 3700 97.7 90 5 2 6400 1 99 29 6.2 3.2 3 1
5 Mr.VinothKumar 27 1 25.5 7000 1 1 10 1 0 0 0 2 0 1 1 1 0 0 0 0 0 0 0 12,000 3,40,000 14.5 65 333 48.2 79 5.6 1 2820 99 1 9.1 6.2 3.2 3.8 2
6 Mrs.Kousalya 58 0 26.5 9000 0 0 0 0 0 0 0 2 1 1 0 0 0 0 0 0 0 0 0 9,300 2,99,000 13.3 36 247 12 149 4.3 2 520 98 2 0.7 6.9 4.3 2.6 0
7 Mrs.Subbathal 74 0 27.3 8000 1 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 13,200 4,46,000 6.2 18 147 5.4 110 3.3 0 2400 55 45 1.93 6.5 2.7 3.8 110 3
8 Mr.Govindaraj 50 1 26.6 4000 1 1 20 2 1 300 1 2 1 0 1 1 0 1 0 0 0 0 1 13,100 2,72,000 9.6 75 1090 27.7 296 4.1 2 13,000 10 90 9.8 6.6 3.7 2.9 1
9 Mr.Balakrishnan 49 1 28.6 3500 1 0 20 2 0 0 0 1 0 1 1 1 0 0 0 0 0 0 0 7,400 2,83,000 14.9 35 195 29.3 104 5.4 1 2500 99 1 0.4 8 4.1 3.9 0
10 Mrs.Gajalakshmi 73 0 26 8000 0 0 0 0 0 0 0 0 1 0 0 2 0 0 1 1 1 0 0 13,300 2,55,000 8.5 33 59 3.4 149 1.2 0 800 40 60 0.5 6.5 3.2 3.3 3
11 Mr.SaddikAli 37 1 28 6000 1 1 30 2 1 800 1 0 1 1 0 2 0 0 0 0 0 0 1 9,400 1,27,000 11.3 44 151 6.9 117 2.6 2 850 62 38 1 5.5 2.6 2.9 515 3
12 Mrs.Visalatchi 50 0 25.7 4500 1 0 0 0 0 0 0 1 0 0 0 1 0 0 1 1 1 1 0 8,000 2,16,000 8.4 35 50 5.8 60 1.6 0 60 85 15 0.8 6.1 3.4 2.7 3
13 Mr.Govindan 80 1 28 9000 1 0 0 0 0 0 0 1 0 1 0 2 0 0 0 1 0 0 1 7,200 2,33,000 8.6 28 108 3 101 2.5 1 600 99 1 0.2 6.8 3.7 2.6 3
14 Mr.LakshmiNarayanan 40 1 27.2 6500 1 0 0 0 0 0 0 1 0 1 0 2 0 0 1 1 1 1 0 13,900 4,46,000 7.7 52 160 4.9 102 3.5 2 780 74 17 2.8 6.5 2.6 2.9 600 3
15 Mrs.Vijayalakshmi 62 0 23.5 7000 0 0 0 0 0 0 0 1 0 1 0 0 0 0 1 1 1 1 0 9,900 2,56,000 9.9 64 123 5.6 229 2 0 780 85 15 2.32 6.5 3.8 2.6 3
16 Mr.Krishnan 52 1 24 4000 1 0 0 0 0 0 0 1 0 1 0 0 0 0 1 0 1 0 1 6,000 2,05,000 9.7 41 89 3.1 103 1.9 1 560 94 6 0.2 6 3.2 2.8 3
17 Mr.Rathinvel 54 1 25.6 9000 1 1 20 1 0 0 0 0 0 1 0 1 0 0 1 0 0 0 1 7,900 3,32,000 12.7 40 534 43 203 5.5 1 1300 83 17 0.6 8.4 4.5 3.9 2
18 Mrs.Bagarth 29 0 23.5 5800 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 8,000 4,12,000 10.8 90 542 53.1 274 5.3 2 11,500 80 20 8.7 6.5 3.3 3.5 2
19 Mr.Subramani 60 1 25.6 3500 1 1 40 2 1 800 1 1 0 1 1 2 0 0 0 0 0 0 0 5,600 6,21,000 9.2 91 409 50.9 55 4 1 650 98 2 3 6.3 3 3.3 2
20 Mr.EdwinThomas 31 1 24.4 7000 1 0 0 0 0 0 0 1 1 1 1 2 0 0 0 0 0 0 0 4,900 3,03,000 14.5 50 496 80.9 79 5.7 1 3,800 96 4 1 5.7 3.4 3.2 2
 
 
  
21 Mr.Nataraj 70 1 25 8000 1 1 10 1 0 0 0 1 0 0 0 2 0 0 0 0 0 0 0 10,800 4,50,000 12.3 56 110 43.4 91 5.5 1 2940 95 5 1.4 7.5 4 3.5 2
22 Mr.Murugesan 19 1 23.3 0 1 0 0 0 0 0 0 1 1 1 0 2 0 0 0 0 0 0 1 7,000 4,81,000 11.1 24 356 37.6 60 3.8 2 12,000 16 80 7.4 6.8 2.8 3.3 2
23 Mrs.Revathi 27 0 25 6000 1 0 0 0 0 0 0 1 0 1 1 1 0 0 0 0 0 0 0 4,600 3,93,000 10.5 43 277 53.3 106 5.1 1 850 96 4 1 6.7 3.1 3.6 2
24 Mr.Myilasamy 54 1 26 8000 1 0 0 0 0 0 0 1 1 1 0 2 0 0 0 0 0 0 1 5,700 2,17,000 12.3 33 3074 125 2 6.5 2 740 42 58 1.42 7.1 3.3 3.8 2
25 Mr.Palanisamy 57 1 27 4000 1 0 0 0 0 0 0 1 0 1 1 2 0 0 1 0 0 0 0 14,800 3,72,000 11.2 60 3273 57.3 192 4.8 2 2500 1 99 23.4 6.8 3.8 3.2 1
26 Mrs.Bagyalakshmi 70 0 25 9600 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 1 0 0 0 13,600 3,56,000 10.5 112 759 46.5 0.8 2.6 2 8000 10 90 14.2 6.8 3.4 3.4 317 1
27 Mrs.Lakshmi 53 0 24.5 7800 1 0 0 0 0 0 0 0 1 1 0 0 0 0 0 1 0 0 1 14,000 3,73,000 9 114 483 13.3 79 4.7 2 800 52 48 1.6 6.5 3.3 3.6 0
28 Mr.KumaranNair 70 1 23 7800 1 1 30 2 1 600 1 1 0 1 0 0 0 1 1 0 0 0 0 8,800 3,06,000 12.8 46 115 38.2 248 5.4 2 1520 93 7 5 6 3.2 3 2
29 Mr.Chinnasamy 46 1 26 7000 1 1 25 2 0 0 0 0 0 1 1 1 0 1 0 0 0 0 0 9,100 57,000 8.6 65 500 17.2 106 3.5 2 7360 11 85 5.5 6 3.7 2.3 1
30 Mr.Kalisamy 50 1 26 7500 1 1 30 2 1 800 2 1 1 0 0 1 0 1 1 1 1 0 0 17,600 2,26,000 13.9 80 804 21.2 138 3.8 2 5120 40 60 8.2 6.2 3.1 3.1 1
31 Mr.Somasundaram 48 1 28 6000 1 1 20 1 1 800 2 0 0 0 0 0 0 0 1 0 0 0 1 6,000 67,000 10.8 60 642 24.2 85 4.3 0 3800 8 92 4.1 7.1 2.8 4.3 1
32 Mr.Palanisamy 61 1 26.2 7000 1 1 25 1 0 0 0 1 0 1 1 0 1 0 1 0 0 1 0 19,700 4,67,000 12 108 34120 469 105 5.6 0 15960 2 98 35.8 7.1 3.5 3.6 1
33 Mr,Thangavel 67 1 25 7600 1 1 20 2 0 0 0 1 0 1 1 1 0 0 0 0 0 0 1 12,900 2,99,000 11.6 51 2921 24.1 1 3.9 0 1300 10 90 3.1 6.7 2.8 3.9 1
34 Ms.Karthika 21 0 23 0 1 0 0 0 0 0 0 0 0 0 1 2 0 0 0 0 0 0 0 20,500 3,25,000 8.7 130 354 12.8 92 4.5 2 5000 13 87 7.7 7.2 3.1 4.1 1
35 Mrs.latha 35 0 24 8000 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 22,800 3,47,000 11.3 90 673 36.9 85 6.7 0 8960 67 33 6 6.8 2.4 3.2 1
36 Mr.Natchimuthu 61 1 25 7800 1 1 20 2 1 600 2 0 0 1 1 1 0 0 1 0 0 0 0 18,400 2,36,000 10.8 102 261 9.5 222 3.7 1 8320 2 98 12 6 2.9 3.1 1
37 Mr.Palanisamy 75 1 27 9000 1 1 20 1 1 500 1 1 0 1 0 1 0 0 0 0 0 0 0 30,000 2,35,000 13.8 11 533 13.1 182 3.7 0 3520 3 97 11.5 5.8 3.4 3.4 1
38 Mr.Bharathan 45 1 27.8 10,000 1 0 0 0 0 0 0 1 0 1 0 1 1 0 0 0 0 0 0 13,700 1,64,000 13.8 30 1054 16.9 6 3.5 2 600 24 76 2.4 6.1 3.7 2.4 573 1
39 Mr.Marimuthu 65 1 24.5 0 1 1 30 1 1 400 1 0 1 0 0 1 0 0 0 0 1 0 1 16,300 3,85,000 8.9 56 814 22.2 105 4.5 2 11,000 10 90 7.3 7.4 2.7 4.6 1
40 Mr.Mariappan 81 1 25.6 5,600 1 0 0 0 0 0 0 1 0 1 0 1 0 0 0 1 0 0 0 11,100 3,46,000 7.9 87 2688 20.8 43 5.5 2 0 0 0 5.6 6.8 3.2 3.4 0
 
 
 
41 Mrs.Poovathal 75 0 25.3 3,500 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 1 0 0 1 8,000 3,64,000 13.2 35 187 13.7 132 6 2 120 98 2 0.4 6.9 3.2 3.5 0
42 Mr.MaheshPrabhu 21 1 25.7 0 1 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 1 8,800 1,63,000 9.6 92 162 35.2 92 5.3 1 680 80 20 4.1 6.5 3.3 3.8 2
43 Mr.Subramani 63 1 26.7 8,500 1 1 20 0 0 0 0 1 0 1 0 2 0 0 1 1 1 1 0 11,400 2,98,000 7.6 15 249 4.8 210 1.2 0 850 32 68 0.4 6.5 2.8 3.2 3
44 Mr.RangaNaicker 75 1 24.3 8,000 1 1 10 0 0 0 0 1 0 0 1 2 0 0 0 1 1 0 0 7,600 2,62,000 9.6 25 58 2.6 116 1.1 0 180 88 12 0.2 6.2 2.6 3.4 3
45 Mr.Kuppusammy 85 1 26.7 10,000 1 1 10 0 0 0 0 0 0 1 0 2 0 0 0 0 1 0 0 5,800 2,16,000 12.8 41 56 2.8 103 1.5 0 460 98 2 0.4 5.8 3.2 3.3 3
46 Mr.Sivaprakashma 55 1 26.3 7,000 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 1 1 13,600 1,27,000 7.6 51 217 10.1 107 1.6 0 2320 68 32 4.3 4.7 2.6 2.1 3
47 Mrs.RadhaBhai 64 0 27.3 0 1 0 0 0 0 0 0 1 1 0 0 0 0 0 1 0 1 0 0 11,800 2,46,000 12.3 34 61 3.1 240 1.4 0 80 95 5 1 6.8 3.2 3.6 3
48 Mrs.Uthamai 51 0 26.7 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 1 11,700 4,69,000 10.6 69 48 2.1 118 1.1 2 800 77 22 2 7.8 3.2 3.8 3
49 Mr.Karuppusamy 50 1 23.4 6,000 1 1 40 0 0 0 0 1 0 1 0 1 0 1 0 0 0 0 0 20,900 2,16,000 14.8 11 102 6.8 64 4 2 200 70 30 0.5 6.8 3.2 3.6 0
50 Mrs.Devi 67 0 24 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 9,000 4,90,000 10.9 50 1120 18.2 134 4.6 2 1000 77 23 1.1 7 3.8 3.2 0
51 Mr.Rajagopal 75 1 27.2 15,000 1 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 1 9,200 1,70,000 10 35 177 11.4 140 4.4 2 500 78 22 0.7 6.8 3.4 3.3 0
52 Mr.Ghouse 43 1 24.3 4,000 1 1 30 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 300 27,000 7.9 120 1563 81.1 67 5.2 0 7000 10 90 8.3 6.4 2.2 3.4 0
53 Mrs.Chellam 47 0 23.5 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 8,900 3,12,000 12.8 60 523 18 66 6.3 2 800 90 10 0.4 6.8 3.2 3.6 0
54 Mr.Raja 28 1 24 4,000 1 0 0 0 0 0 0 0 0 1 1 2 0 0 0 0 0 0 1 6,300 3,58,000 10.8 59 1082 57.6 89 4 1 1960 93 7 1.5 7.1 3.5 3.5 0
55 Mr.Bhaskaran 64 0 26.1 10,000 1 1 40 0 0 0 0 1 0 1 0 1 0 1 0 0 0 0 0 13,400 2,50,000 17.3 1 382 25.1 124 6.1 2 3200 50 48 1.9 7.1 3.8 3.3 0
56 Mr.Rangesh 52 1 24 6,000 1 1 30 1 1 300 1 1 0 1 0 1 0 0 1 0 0 0 0 14,600 5,38,000 12.8 90 2722 93 6 4.6 1 3600 3 97 4.8 6.8 3 3.8 2
57 Ms.Aishwarya 18 0 22 0 1 0 0 0 0 0 0 0 1 1 1 1 0 0 0 0 0 0 0 5,500 1,85,000 11.7 30 648 68.6 80 5.4 1 2220 70 30 1.8 7.7 3.6 3.3 2
58 Mr.Karuppan 80 1 24 6,000 1 0 0 0 0 0 0 1 1 1 1 1 0 0 0 0 0 0 0 85,000 1,67,000 6 60 478 30 81 6.7 1 2000 99 1 1.52 6.7 3.3 3.4 2
59 Mrs.Vimala 27 0 23 3,500 1 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 7,100 1,87,000 10.7 85 856 54.7 62 5.2 2 3800 98 2 7.72 6.8 3.6 3.7 2
60 Mr.Palanisamy 60 1 26 6,000 1 1 30 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 15,000 5,55,000 12 26 1366 11.9 83 3 2 9600 98 2 0.8 6.8 3.3 3.5 964 0
